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Abstract
Adventists following a plant-based diet have half the prevalence and incidence of type 2
diabetes than nonvegetarian Adventists. This study used a quantitative, correlational
study design to assess if there was a significant difference in type 2 diabetes prevalence
rate between Adventists and non-Adventists preprogram, and if there were significant
differences in biometrics between Adventists and non-Adventists with diabetes pre- and
post-Complete Health Improvement Program (CHIP). This study incorporated the social
ecological model for its conceptual framework and examined pre- and postprogram
changes among Adventists (n=210; 20.1%) and non-Adventists (n=836; 79.9%) with type
2 diabetes. It used secondary data from participants in the volunteer-delivered CHIP
intervention from 2006 to 2012 (n=7,172), a whole foods, plant-based, vegan health
program. Analysis showed a significant difference in the pre-CHIP diabetic state between
the two groups in step one, but not after controlling for covariates in step two (OR=0.96
and 0.91; CI=1.21 and 1.24). A repeated measures MANOVA analysis indicated that
religious affiliation (Adventist or non-Adventist) was the determining factor in improved
biometric outcomes pre- and post-CHIP for TC (F(1) = 5.65; p = 0.02), and LDL (F(1) =
5.76; p = 0.02) but not for HDL (F(1) = 0.00; p = 0.99), TG (F(1) = 0.19, p = 0.67), FPG
(F(1) = 2.71, p = 0.10), SBP (F(1) = 2.25; p = 0.13), DBP (F(1) = 1.20; p = 0.27), and
BMI (F(1) = 1.65; p = 0.20). However, both groups improved post-CHIP in all
biometrics. The implications for positive social change from this study showed that CHIP
is an effective lifestyle model for improving type 2 diabetes outcomes for both Adventists
and non-Adventists, a model that does not involve the use of pharmaceuticals.
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Chapter 1: Introduction to the Study
Introduction
The two main types of diabetes are type 1, formerly referred to as insulindependent diabetes or juvenile diabetes, and type 2, formerly referred to as adult-onset
diabetes. Type 1 diabetes is characterized by an absolute deficiency of insulin, and type 2
is characterized by insulin resistance and a progressive deficiency in insulin production
(ADA, 2016). Type 1 diabetes accounts for 5-10% of all diabetes cases, and type 2
diabetes accounts for 90-95% (ADA, 2016). In 2009, 191,986 (0.25%) youth in the
United States aged 0 to 19 years had diabetes, with 20,262 of those youth having type 2
(Pettitt et al., 2014); this number is expected to quadruple by 2050 (Imperatore et al.,
2012). Prevalence is significantly higher in U.S. adults: 29.1 million (9.3%) have type 2
diabetes and 1.7 million acquire it annually (ADA, 2013). Previous research has
suggested an association between improved glycemic control and biometrics after
switching to a vegetarian diet (Barnard, Katcher, Jenkins, Cohen, & Turner-McGrievy,
2009; Yokoyama, Barnard, Levin, & Watanabe, 2014). This research study focused on
type 2 diabetes and included all ages.
This study was specifically designed to investigate dietary and religious
influences on diabetes treatment. Seventh-day Adventists (Adventists) who follow a
plant-based (vegan) diet have approximately half the prevalence and incidence of
diabetes compared to nonvegetarian Adventists and with lower rates of metabolic
syndrome (Le & Sabate, 2014; Orlich & Fraser, 2014; Tonstad et al., 2013). Adventists
are known for their healthful and similar baseline lifestyle, which is a foundational
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teaching in this conservative, Protestant movement (Butler et al., 2008). This makes
Adventists an ideal group for use in studying the relationships between diet and disease.
Adventists show an unusual behavioral homogeneity that makes them an ideal
comparative group. Since its conception as an organization in the 1860s, this group has
been taught by proscription to abstain from tobacco (98.9%), alcohol (95.4%), illicit
drugs, and caffeine; this adherence significantly reduces the confounding effects of
nondietary factors (Butler et al., 2008). Adventists also abstain from Biblically unclean
meats such as pork and shellfish (Leviticus 11, King James Version); although a
vegetarian diet is not required, it is advocated within their membership (Phillips, Kuzma,
Beeson, & Lotz, 1980). A typical Adventist diet emphasizes fruits, vegetables, whole
grains, legumes, and nuts, while discouraging rich desserts, spices, and highly refined
foods; members are also encouraged to exercise (Butler et al., 2008; Phillips, Kuzma,
Beeson, & Lotz, 1980). With this consistent foundation, Adventists then have a wide
spectrum of diets from eating meat to being total vegetarian (often referred to as vegan),
abstaining from all animal products including eggs, dairy, and all flesh meats. NonAdventist research also suggests that meat consumption increases the risk of type 2
diabetes, and by switching to a vegan or vegetarian diet (includes dairy and eggs but
excludes animal flesh), diabetes outcomes improve (Barnard, Levin, & Trapp, 2014;
Fung, Schulze, Manson, Willett, & Hu, 2004; Pan et al., 2013).
This study examined the Adventist health message through the social ecological
model (SEM; Bronfenbrenner, 1979) and how that health message has been incorporated
into each level of society. It specifically used data from the Complete Health
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Improvement Program (CHIP; formerly known as the Cardiac Health Improvement
Project; Diehl, 1998), an Adventist-run program that has produced multiple influences at
the individual, social, community, and institutional levels.
CHIP is a 30-day, professional- and volunteer-delivered, video-presented,
community-setting, plant-based, whole-food, vegan, lifestyle modification program that
has been adopted by the Seventh-day Adventist (Adventist) church. CHIP was designed
to improve and target those with type 2 diabetes and cardiovascular disease (Rankin et
al., 2012). The foundational CHIP intervention was based on a number of theoretical
frameworks, but most strongly draws on the theory of planned behavior (TPB; Ajzen,
1985). As a result, it has a strong educational component to help people change attitudes,
social norms, and perceived control towards leading healthier lifestyles (Morton et al.,
2014a). This dissertation, however, diverged from this earlier foundation by being based
on the social ecological model (SEM) described by Bronfenbrenner (1979).
The CHIP lifestyle intervention program, now referred to simply as CHIP, works
with volunteers and professionals to deliver a video-based health program in a
community setting (Morton, Rankin, Kent, & Dysinger, 2014a). The first 30-day CHIP
lifestyle intervention was presented in 1988 and recorded in 1997, which allowed both
professionals and trained CHIP volunteers to administer the program in their perspective
and separate settings. At the time of this study, over 70,000 participants have gone
through the program worldwide and is described in more than 25 publications (Morton et
al., 2014a).
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This present study drew on data and other information from 25 peer-reviewed
studies on the CHIP program. Seventeen of these studies examined formally educated
healthcare professionals who delivered the CHIP lifestyle intervention. Seven of these
studies examined volunteers who may or may not have been medically trained. One study
summarized the history of CHIP for both professionals and volunteers. This dissertation
focused on the volunteer branch of the CHIP intervention. CHIP founder, Dr. Haans
Diehl videotaped sixteen 2-hour presentations and made them available in 1997 to lay
people (mainly Adventists) who had an interest in improving the health of people in their
local communities (Rankin et al., 2012). Being a health professional was not a criterion
since the program directors had only a facilitator’s role, not an educator’s role (Rankin et
al., 2012). In these interventions, Diehl gave health education instruction via recorded
video and volunteers directed group discussions, presented cooking demonstrations, and
provided grocery store tours. Adventists have presented most CHIP programs.
Earlier CHIP studies have compared mean changes pre- and postprogram in terms
of overall participation and between genders. However, this prior research had not
determined if there was a prevalence rate difference of self-identified type 2 diabetes
between Adventists and non-Adventists pre-CHIP, and if having a particular religious
belief (Adventist or non-Adventist) affected biometric outcomes (total cholesterol [TC],
high-density lipoproteins [HDL], low-density lipoproteins [LDL], triglycerides [TG], and
fasting plasma glucose [FPG], systolic blood pressure [SBP], diastolic blood pressure
[DBP], and body mass index [BMI]) in those with type 2 diabetes. This dissertation
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addressed this gap in the literature by tracking biometrics via the biomarkers TC, HDL,
LDL, TG, and FPG, and clinical parameters of SBP, DBP, and BMI.
Since its inception in the 1860s, the Adventist church has had a consistent,
worldwide commitment and a rich history of positive social change by providing
education for the prevention of disease and the relief of sickness in a variety of societal
settings (Fraser, 2003). This study investigated some of the foundational elements of this
social change education: giving participants the tools they needed to start and maintain a
positive healthy lifestyle, and teaching the benefits of doing such. The study’s implication
for positive social change consists of determining whether the Adventist health message,
as presented through CHIP, is an effective non-medical, whole-food, plant-based,
lifestyle model in improving type 2 diabetes outcomes for Adventists and non-Adventists
similarly. A planned outcome was determining whether the Adventist health message is
appropriate for use as a source of inspiration, optimism, strength, and guidance in health
challenges for all who choose a dietary approach to diabetes prevention and reversal
without the use of pharmaceuticals, regardless of faith belief.
Background of the Topic
The Adventist church has taught a progressive health reform message since its
inception in the mid-1800s, including both a unique council on health and the founding of
many new health-related organizations (Douglass, 1998). Adventists have published
health literature showing a connection between lifestyle, diet, spirituality, and disease;
they opened up their first sanitarium in 1866, the Western Health Reform Institute in
Battle Creek, Michigan, later renamed Battle Creek Sanitarium (Robinson, 1943). The
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Battle Creek Sanitarium applied the above unique health principles with successful
patient outcomes, although the principles had not yet been validated scientifically
(Robinson, 1943, p. 152). Since then, both Adventists and non-Adventists have started
other similar programs that have since been scientifically validated (Fraser, 2003).
Sanitariums, or live-in residential lifestyle programs such as Battle Creek Sanitarium,
provide a controlled setting where participants learn to optimize their lifestyle through a
whole-food, plant-based diet, exercise, and other healthful principles (Crane & Sample,
1994; McDougall et al., 2014, Slavicek et al., 2008). Examples of extant lifestyle centers
include the Weimar Institute, Uchee Pines Institute & Lifestyle Wellness Center,
Wildwood Lifestyle Center & Hospital, Eden Valley Institute of Wellness, Pritikin
Longevity Center, and BellaVita Lifestyle Center.
In the mid-1950s, longitudinal studies by both Adventist and non-Adventist
groups began to validate scientifically associations among incidence, prevalence,
predisposing factors, and prognosis with lifestyle, diet, and disease. Some of these longterm studies include the following:
•

the Framingham Study (Castelli et al., 1986)

•

the Nurses’ Health Study I and II, the Health Professional Follow-Up Study (Pan
et al., 2011)

•

the Adventist Health Study 1 and 2 (Rizzo, Sabate, Jaceldo-Siegl, & Fraser, 2011;
Tonstad, Butler, Yan, & Fraser, 2009; Tonstad et al., 2013)

•

the Adventist Mortality Study (Vang, Singh, Lee, Haddad, & Brinegar, 2008),

•

the Adventist Religion & Health Study (Lee et al., 2009)
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•

the Adventist Health Air Pollution Study (Chen et al., 2005)
Community lifestyle programs added yet another educational dimension to

teaching about lifestyle, while also teaching foundational health principles to prevent and
reverse chronic disease in a stay-at-home setting. These programs are offered in a variety
of settings:
•

in the workplace (Levin, Ferdowsian, Hoover, Green, & Barnard, 2010)

•

through local research studies (Knowler et al., 2002)

•

through randomized, controlled studies (Barnard et al., 2009a)

•

through private physician offices (Crowe, Ellis, Esselstyn, & Medendorp, 1995)

•

at hospitals and clinics (Englert, Eiehl, Greenlaw, Willich, & Aldana, 2007)

•

by faith-based groups such as CHIP (Kent et al., 2013a)
Prior research on the CHIP intervention showed that men improved more than

women in all biometrics except high-density lipoprotein (HDL; Kent, Morton, Rankin,
Gobble, & Diehl, 2014). In this research, HDL dropped lower in women (7.6% versus
9.1%), and those with the worse biometrics made the greatest improvements because they
had the greatest amount of room to change (Kent et al., 2014). The value of monitoring
HDL when assessing a change to a plant-based diet has been questioned since this and
other research has observed a drop in HDL phenomenon despite overall cardiovascular
risk improvement (Barnard, 1991; Esselstyn et al., 1995; Kent et al., 2013b; Morton et
al., 2013; Ornish et al., 1998; Rankin et al., 2012). CHIP research has shown that the 30day program has had the following effects:
•

men reduced their body mass index (BMI) by 3.5% and women by 3.0%
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•

men reduced systolic blood pressure (SBP) by 5.5% and women by 5.1%

•

men reduced diastolic blood pressure (DBP) by 5.9% compared to 4.8% for
women

•

men reduced total cholesterol (TC) by 13.2% compared to 10.1% for women

•

men reduced low-density lipoproteins (LDL) by 16.3% compared to 11.5% for
women

•

men reduced triglycerides (TG) by 11.4% compared to 5.6% for women

•

men reduced fasting plasma glucose (FPG) by 8.2% compared to 5.3% for women
(Kent et al., 2014; Morton et al., 2014a)
Although CHIP is an Adventist-driven program, research has focused on

outcomes comparing genders, and pre- and postbiometrics in general. However, the
literature review did not identify research that compared whether coupling a certain
religious belief with type 2 diabetes may differ in outcomes between Adventists and nonAdventists. Until now, it was unknown if being an Adventist or non-Adventist elicited
different biometric outcomes pre- and post-CHIP in those with type 2 diabetes, and if
there was a difference between the incidence rate of Adventists and non-Adventists who
have self-identified themselves as having type 2 diabetes preprogram.
Problem Statement
Type 2 diabetes is a national problem in the United States and globally (American
Diabetes Association [ADA], 2015). Each year, approximately 1.7 million people in the
United States acquire type 2 diabetes, in addition to the 29.1 million who already have
the disease, which takes the life of almost 74,000 people annually, costing the national
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healthcare system billions of dollars per year (ADA, 2013). Since 2002, the total U.S.
economic cost of diabetes has risen from $132 billion (ADA, 2003) to over $245 billion
in 2012 (ADA, 2013). Seventy percent of people with diabetes will die from
cardiovascular disease (CVD), which includes heart disease—the number one cause of
death and disability for those with diabetes (Zhao et al., 2014). The foundational
treatment for diabetes and CVD is diet and lifestyle (Dinu, Abbate, Gensini, Casini, &
Sofi, 2016); however, this has historically been given little attention compared to
pharmaceuticals (ADA, 2015).
CVD costs in the United States are alone projected to triple from $273 billion in
2010 to $818 billion in 2030 (Heidenreich et al., 2011). Coronary heart disease (CHD)
causes about 720,000 heart attacks each year, resulting in 380,000 deaths in the United
States annually at a cost of $108.9 billion (Murphy et al., 2013). Some of the current,
well-recognized risk factors of type 2 diabetes include the following:
•

being overweight (Biggs et al., 2010)

•

inactivity (Hu, 2003; Jeon, Lokken, Hu, & van Dam, 2007; Plotnikoff, Costigan,
Karunamuni, & Lubans, 2013)

•

improper nutrition (Barnard et al., 2009; Pan et al., 2011; Tonstad et al., 2013)

•

high blood pressure, cholesterol, and blood sugars (Rosner et al., 2009)

•

statin medications (Mansi, Frei, Wang, & Mortensen, 2015; Macedo, Douglas,
Smeeth, Forbes, & Ebrahim, 2014).
The problem addressed by this study is that the current dietary recommendations

set forth by the American Diabetes Association (ADA) do not address the root cause of
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type 2 diabetes, but instead manage it primarily through medications and moderate intake
of all foods, regardless of their health value (ADA, 2016). A whole food, plant-based
diet, without the use of animal products, improves blood sugar control better than
pharmaceuticals (Knowler et al., 2002) and the standard diabetes diet (Barnard et al.,
2009) without the negative side effects of pharmaceuticals (Graham et al., 2010).
Moreover, some foods are more problematic, like processed carbohydrates, dairy, eggs,
fat, and animal protein (Djousse, Khawaja, & Gaziano, 2016; Hu, Pan, Malik, & Sun,
2012; Lawlor, Ebrahim, Timpson, & Smith, 2005; Pan et al., 2013; Vitale et al., 2015),
and others are more beneficial, like whole-plant foods and a vegan diet (Tonstad et al.,
2013, Turner-McGrievy, 2008). Those with diabetes also improve FPG by replacing red
meat with legumes (Hosseinpour-Niazi, Mirmiran, Hedayati, & Azizi, 2014) and by
reducing red meat consumption (Pan et al., 2013). Vegetarian and vegan Seventh-day
Adventists have reduced incidence (Tonstad et al., 2013) and prevalence (Tonstad et al.,
2009) of diabetes and metabolic syndrome (Rizzo, Sabate, Jaceldo-Siegl, & Fraser,
2011), suggesting that dietary content has a significant effect. Additional evidence
supporting this includes a drop in mortality rate (Heuch, Jacobsen, & Fraser, 2005) and
ischemic heart disease the longer Adventists have been baptized members and following
the recommended lifestyle (Snowdon, Phillips, & Kuzma, 1982). During a 1960s
Adventist study, members baptized as children died at 71% the risk as members baptized
as adults, signifying that the younger members changed their lifestyle to a vegetarian diet,
the stronger their protection in dying from ischemic heart disease (Snowdon et al., 1982).
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Although CHIP is an Adventist-facilitated program, a gap in the literature existed
in relation to assessing if the CHIP lifestyle affected Adventists and non-Adventists
differently. This current research assessed if those with a particular religious belief
(Adventist) experienced different outcomes from the CHIP program when compared to
those who did not hold that religious belief (non-Adventist). It was also unknown
whether Adventists entered the CHIP program with a different prevalence rate of selfidentified diabetes. This dissertation therefore compared eight biometric outcomes preand post-CHIP in Adventists and non-Adventists with type 2 diabetes, and assessed
whether there was a difference in the self-identified diabetes rate between Adventists and
non-Adventists pre-CHIP.
Purpose of the Study
This quantitative, correlational study analyzed secondary data to assess how
Adventist affiliation affected biometric outcomes. It specifically compared how having a
particular religious belief (Adventist or non-Adventist) for those with type 2 diabetes
affects eight biometric outcomes—TC, HDL, LDL, TG, FPG, SBP, DBP, and BMI—for
pre- and post-CHIP intervention, while controlling for four covariates. It also specifically
assessed if Adventists or non-Adventists entered the program with a statistically
significant different rate of self-identified diabetes while controlling for five covariates.
Prior research suggested that Adventists enter the CHIP program with improved baseline
risk factors over non-Adventists, but non-Adventists see greater improvements because
there was more room for improvement (Rankin, 2014). It was unknown how the
Adventist religious belief system specifically affected CHIP biometric outcomes in those
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with type 2 diabetes, although other research has revealed that religiosity can improve
those outcomes (Eleuterio da Silva, Eleuterio da Silva, Marcilio, & Pierin, 2012). An
examination of the research reveals limited studies comparing Adventists to nonAdventists.
Research Questions and Hypotheses
The following research questions guided this study:
Research Question 1 (RQ1): After controlling the effects of age, gender, marital
status, BMI, and parental death from diabetes before age 60, is there a statistically
significant difference in self-identified type 2 diabetes prevalence rates between
Adventist and non-Adventist CHIP participants preprogram between January 2006 and
September 2012?
H01: The self-identified diabetes prevalence rate between Adventist and nonAdventist in pre-CHIP participants is not significantly different.
H11: The self-identified diabetes prevalence rate between Adventists and nonAdventists in pre-CHIP participants is significantly different.
The dependent variable tracked in answering RQ1 was self-identified diabetes.
The independent variables were religiosity and testing period. Five covariates were also
tracked: age, gender, marital status, BMI, and parental death from diabetes before age 60.
The quantitative test used to answer this question was logistic regression.
Research Question 2 (RQ2): After controlling for the effects of age, gender,
marital status, and parental death from diabetes before age 60, is there a statistically
significant difference in the change in biometric outcomes (TC, HDL, LDL, TG, FPG,
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SBP, DBP, and BMI) between Adventists and non-Adventists with self-identified
diabetes pre- and post-CHIP between January 2006 and September 2012?
H02: There is no statistically significant difference in biometric outcomes
between Adventists and non-Adventists with self-identified type 2 diabetes pre- and postCHIP.
H12: There is a statistically significant difference in biometric outcomes between
Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-CHIP.
The dependent variables tracked in answering RQ2 were TC, HDL, LDL, TG,
FPG, SBP, DBP, and BMI. The independent variables were religiosity and testing period.
The covariates were age, gender, marital status, and parental death from diabetes before
age 60. The quantitative test used to answer RQ2 was a multiple analysis of variance
(MANOVA).
Conceptual Framework for This Study
The conceptual framework for this research was based on the social ecological
model (SEM) developed in the late 1970s by Urie Bronfenbrenner. SEM was initially
developed to understand the factors that influenced and prevented violence in child abuse
(Bronfenbrenner, 1979). The SEM is now used to explain the interconnectedness and
often complex and evolving associations among society, community, interpersonal
relationships, and individuals (Bronfenbrenner, 1994). In the initial model, these four
associations were in a nested structure, each inside the other with the innermost position
containing the individual. Moving outward, the next position was interpersonal
relationships, then community, and the outermost structure was society. SEM provides a
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systems way of looking at human behavior in which each level is often fluid and
interactive with other levels. To make large societal changes, SEM suggests
understanding the problem from each social level, then affecting each level appropriately
through educational efforts. As each social level creates its own change, it affects all the
other levels interchangeably.
For example, the initial SEM (Bronfenbrenner, 1979) instituted to explain abuse.
The first or innermost level identified individual settings or characteristics that affect
abuse, which may be, for example, in the home environment or classroom setting, and
included being either the perpetrator or victim. Factors that influenced abuse included age
of the child, stress level, family history of abuse, substance abuse, having a rigid belief
system, and limited educational attainment (Dahlberg & Krug, 2002). In a preventative
approach at the individual level, the educational outreach approach may include targeting
and training for childcare staff, pediatricians, schoolteachers, and counselors.
The second layer out, next to the individual position, is interpersonal
relationships, which looks at the interconnectedness between environments and
relationships among those within the closest social circle (Krug, Mercy, Dahlberg, &
Zwi, 2002). This level looked at family members, peers, and partners who have influence
in the environment. In a preventative approach at the interpersonal relationship level,
education may include mentoring and peer programs to improve problem-solving skills
and parenting skills, as well as reducing seclusion.
The third level takes a broader view yet by looking at the outward community
settings, such as schools, neighborhoods, workplaces, and other places where social
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relationships occur and abuses happen. In a preventative approach, the strategies targeted
changing the climate of these places, including after-school programs, recreation center
activities, and family fun nights (Bronfenbrenner, 1979). Focusing on community settings
fosters safer neighborhoods, schools, and communities.
The outermost or fourth level looks at the society at large, creating a broader
influence that inhibited abuse through cultural and social norms (Krug et al., 2002).
Societal strategies included targeting social media, health and education policies, social
and economic policies, and social norm campaigns. Focusing on the societal level
changes the way the public thinks, and when facing a particular situation, society would
ideally take a more positive approach. Each of the four influential levels of society work
together to create change, individuals learn new norms in every social level.
Since the time of the original model, Bronfenbrenner (Bronfenbrenner, 1994) and
others (Attorney General’s Sexual Assault Task Force, 2006; Golden, McLeroy, Green,
Earp, & Lieberman, 2015) have continued to modify, update, and revise the SEM. It now
includes institutions as a fifth social influence, and nestles it in between community and
societal as its new fourth layer, with societal being bumped out to the fifth level.
Realizing that institutional processes also play a role in social influence and behavior
change—such as anti-bullying programs, strict anti-abuse laws, zero tolerance policies,
group home rules and staff training, media education, and guidelines for reporting
abuse—this additional social layer was also added. The SEM attempts to explain human
behavior as it relates to the interrelationships among each social influence and recurring
patterns. The SEM has also been expanded to a wide variety of health promotion settings,
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which views the person and the differing social environments as interlinking influences
(Raingruber, 2014, p. 64).
Given the complexity of a comprehensive, multilevel, health promotion
intervention, it is essential to consider the individual, relational, community, institutional,
and societal impacts that influence and sway health outcomes. Targeting one specific
social level about health would not be as effective as simultaneously concentrating on
multiple health factors considering healthy and unhealthy lifestyle principles come from
each social level in reciprocal influences (Raingruber, 2014, p. 64). The SEM assumes
people are more likely to succeed when multiple supportive social environments are
activated, cumulative, and combined, which all influence, shape, and support one other.
The dissemination of the Adventist health message has taken similar shape, reaching
every sector of society, with CHIP intersecting three of those levels. See Figure 1.
At its inception in the 1860’s, the Adventist church’s foundation was built upon
the biblical mandates of Matthew 28:19-20 and Revelation 14:6-12 to go into all the
world to proclaim the gospel. Adventists believe that the gospel message includes the
responsibility to care for their body, which has guided much of their outreach (1
Corinthians 3:16; 2 Corinthians 6:16; 3 John 2; Romans 12:1-2; Seventh-day Adventist
World Church, 2016). The church has embraced its signature health message following
the example of Jesus to relieve suffering (Matthew 15:29-31), believing there is a
connection between healthful living, a clear mind, a healthy body, and true worship
(White, 1909, ST, para. 7-9).
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With its unique vision of promoting health in all sectors of society, the Adventist
health message has naturally fit into the SEM model. CHIP takes shape within the
community setting but also influences the relationship-building and individual
environments in society. CHIP is one educational piece within the entire Adventist
Health Message. At an individual level, health reform is encouraged by the church
(General Conference of Seventh-day Adventists, 2010, p. 91; White, 1948, 9T, p. 158)
through personal Bible study, reading healthful living books penned by Ellen G. White,
and in keeping up to date with current day research that still fits into the Adventist health
principles foundation. It is from these sources that knowledge, skills, attitudes, and CHIP
principles are learned and encouraged. In that inner social sphere, each CHIP participant
makes the necessary healthful changes they learned throughout the program to improve
their TC, HDL, LDL, TG, FPG, BMI, SBP, and DBP. In order to investigate the
intersection of religion and health, this dissertation also included the covariates of age,
gender, marital status, BMI, and parental death from diabetes before age 60, since each
one has been shown to be a factor in diabetes development.
In the second outer social sphere, relationship building, or social networking,
friends, family, and church groups model the Adventist health message and CHIP’s
healthful teachings to one another, where people learn new social norms through the local
church via health sermons, bulletin inserts often termed health nuggets, and small support
groups such as CHIP (General Conference of Seventh-day Adventists, 2010, p. 26-27,
139-140). In the third social sphere, community influence, the Adventist church offers
community health lectures and classes such as CHIP, Pathway to Health, independent
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ministry health outreach, plant-based, vegan cooking classes, and stop-smoking,
depression, and stress-control programs (General Conference of Seventh-day Adventists,
2010, p. 91; White, 1948, 9T, p. 112).
The fourth and more broad social sphere, institutional influences, includes the
Adventist Development & Relief Agency (ADRA) for disaster relief and health
dissemination, publishing agencies, and Adventist Book Centers where a host of
literature may be purchased (General Conference of Seventh-day Adventists). The fifth
and most outer social sphere contains the societal influences the Adventist church uses as
its broadest form of health education and outreach, and includes worldwide Adventist
television and satellite with their health programs, the Blue Zone, the Adventist health
studies as published research, and the worldwide Adventist health care system (White,
1938, p. 75).
Within the multifaceted social ecological model, the Adventist health message
touches each level of the social sphere from personal to relational, community,
institutional, and societal, with CHIP influencing many levels. Each social sphere is
influenced by the next, and the environment is continually being shaped depending on
whom each one meets and learns from (Raingruber, 2014, p. 65). One does not have to be
a member of the Adventist church to be influenced by one or more of the many levels of
the church’s health message. The majority of the CHIP participants are non-members,
and the church’s health message permeates every level of society.
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INDIVIDUAL/INTRAPERSONAL FACTORS
Knowledge, skills, attitudes, &
lifestyle changes learned from CHIP,
Bible reading, and personal readings
on health

RELATIONSHIP BUILDING
Social networking: Friends, family,
CHIP & other support groups, church,
learning new norms, health sermons,
healthy cooking classes

COMMUNITY INFLUENCE
CHIP intervention, Pathway to Health, independent
ministries, 5-day stop smoking programs, health
classes, evangelistic outreach with health emphasis,
lifestyle centers/sanitariums, and published material,
vegetarian restaurants, food industry

INSTITUTIONAL INFLUENCES

Adventist school system, Adventist
Development & Relief Agency,
publishing agencies, book centers

SOCIETAL INFLUENCES

Adventist television & satellite with
health programming, Blue Zone,
Adventist Health Study published
research, Adventist Health Care
System

Figure 1. Societal influences of the Adventist health message depicted through the social
ecological model.
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Nature of the Study
The nature of this study was a quantitative, correlation research design, which
used secondary data excluding identification markers, having received permission from
CHIP researchers to share their data for the purpose of this dissertation. Data was
collected from 241 programs from 163 sites, between January 2006 and September 2012,
involving 7,172 individuals. Volunteer directors underwent a 2-day training seminar to
receive training manuals, program content, and instruction on how to deliver the sixteen
2-hour group sessions. Program content included its philosophy and methods and how to
lead cooking classes, grocery store tours, group discussions, and exercise classes, and the
prerecorded video education. Video instruction included education on a plant-based diet,
exercise, behavioral change, self-worth, modern medicine’s strengths and weaknesses,
smoking, cholesterol, fiber, lifestyle and health, and epidemiology and risk factors of
CVD, type 2 diabetes, atherosclerosis, hypertension, obesity, and dyslipidemia.
Pre- and post-CHIP measurements included blood samples for TC, HDL, LDL,
TG, and FPG, and height and weight for BMI, and blood pressure (BP), and were the
variables for this study. The dependent variable in RQ1 were self-identified diabetes, and
the independent variables were religiosity and testing period. The covariates were age,
gender, marital status, BMI, and parental death from diabetes before age 60. The
dependent variables in RQ2 were TC, HDL, LDL, TG, FPG, SBP, DBP, and BMI, with
religiosity and testing period as independent variables. The covariates were age, gender,
marital status, and parental death from diabetes before age 60. Diet, race, income, and
exercise information were not captured and are therefore not available. Only participants
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who attended 13 of 16 sessions and completed a self-reported medical, lifestyle prequestionnaire and pre- and postassessments were defined as graduated and included in
this study.
A quantitative correlational research design was chosen for this research since it
provided valuable data for looking at relationships between variables, with the intent to
generalize findings from a sample to a population (Creswell, 2009), testing the impact of
the interventional CHIP program on a specified group of people. The variables were
measured using the statistical analysis of MANOVA and regression analysis. The final
report was controlled for confounders, protected against biases, and reproducible and
generalizable to the population. Traditionally, quantitative designs provide reliability,
objectivity, as well as internal and external validity (Trochim & Donnelly, 2008).
Operational Definitions
Body mass index (BMI): A measurement of body fat in relation to weight and
height. BMI is calculated by dividing weight in kilograms by height in meters squared.
BMI is a screening tool to categorize weight from underweight, normal weight,
overweight, to categories of obesity (Garrow & Webster, 1984). CHIP used the World
Health Organization (WHO) BMI categories, measured as kg/m² (Alberti & Zimmet,
1998). A normal BMI is 18.5 to 24.9 kg/m².
Complete Health Improvement Program (CHIP): A 30-day intensive,
community-based, plant-based, video-delivered, comprehensive health education, and
lifestyle program (Diehl, 1998).
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Diastolic blood pressure (DBP): The bottom number of the two numbers
recorded when the blood pressure is taken. It is the relaxation phase of the heart after
pressure has been placed against the wall of the blood vessel, and blood fills the heart
again. CHIP used the NCEP Treatment Panel III classification system to categorize DBP,
measured in mmHg (NCEP, 2002). A normal diastolic pressure is <80 mmHg.
Fasting plasma glucose (FPG): A measurement of blood sugar without caloric
intake for at least eight hours. CHIP used the Treatment Panel III classification system to
categorize FPG, measured in mg/dL (NCEP, 2002). A normal FPG for this study is
considered <110 mg/dl.
Graduate: In the context of this study, a CHIP participant who attended 13 of 16
CHIP sessions, completed a self-reported medical and lifestyle prequestionnaire, and
completed pre- and postassessment questionnaire (Kent et al., 2014).
High-density lipoproteins (HDL): A carrier of cholesterol through the blood
stream, typically thought of as good cholesterol. CHIP used the National Cholesterol
Education Program (NCEP) Treatment Panel III classification system to categorize HDL,
LDL, and TG, measured in mg/dL (NCEP, 2002). A normal HDL is 40-60 mg/dl.
Low-density lipoproteins (LDL): A carrier of cholesterol through the bloodstream,
typically thought of as bad cholesterol. CHIP used the NCEP Treatment Panel III
classification system to categorize HDL, LDL, and TG, measured in mg/dL (NCEP,
2002). A normal LDL is <100 mg/dl.
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Plant-based diet: A diet based upon fruits, vegetables, whole grains, legumes, and
nuts, without the use of animal products. Referred to as the Optimal Diet in CHIP
(Englert et al., 2004). Often also called a vegan or total vegetarian diet.
Professionally-delivered: In the context of this study, a term to describe a delivery
of the CHIP program in a workplace or clinical setting by formally trained and educated
health professionals (Morton et al., 2014a).
Self-selected: CHIP participants choosing to participate in the health education
program and paid for this service (Diehl, 1998).
Seventh-day Adventist (Adventist): A member of a conservative, Protestant,
worldwide, and growing body of about 18 million members with a worldwide focus on
health and health outreach (Seventh-day Adventist World Church (SDAWCH), 2015a).
Systolic blood pressure (SBP): The top number of the two numbers recorded
when the blood pressure is taken. It is the pressure phase exerted on the blood vessel
walls as the heart constricts, pushing blood out of the heart into the body. CHIP used the
NCEP Treatment Panel III classification system to categorize SBP, measured as mmHg
(NCEP, 2002). A normal SBP is <120 mmHg.
Total cholesterol (TC): A blood test result showing the sum total of circulating
LDL, HDL, and very low-density lipoprotein (VLDL). CHIP used the Framingham Risk
Classification for stratifying TC, measured in mg/dL (Wilson et al., 1998). A normal TC
is <160 mg/dl.
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Triglycerides (TG): A form of fat in blood. CHIP used the NCEP Treatment Panel
III classification system to categorize TG, measured in mg/dL (NCEP, 2002). A normal
TG is <150 mg/dl.
Type 2 diabetes: A metabolic disorder with glucose inefficiency coupled with
overproduction (Sacks et al., 2011). A diagnosis of diabetes requires a FPG of >125
mg/dL on two separate occasions (ADA, 2016)
Volunteer-delivered: In the context of this study, a term to describe delivery of the
CHIP program by facilitators mainly sourced from the Adventist church who wanted to
positively affect their community. Facilitators participating in volunteer-delivered
services required no special formal education, they instead attended a 2-day training
seminar to develop facilitator skills and receive certification (Kent et al., 2014).
Assumptions
A plant-based diet is typically lower in calories, fat, trans fats, cholesterol, and the
glycemic index, as well as being higher in fiber and nutrient density than the typical
American diet (Barnard et al., 2009b; Levin et al., 2010) and the diet set forth by the
American Diabetes Association (ADA; Barnard et al., 2009a). My assumption was that as
individuals with diabetes from both faith groups switch from the standard American diet
(SAD) to a plant-based diet, both would see improvements in their biometric outcomes,
but it was unknown as to whether one group would outperform the other due to their faith
group. Those on a vegan diet develop diabetes at a rate of 0.54%, which is significantly
lower than the 2.12% rate for those on nonvegetarian diets (Tonstad et al., 2013).
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Similarly, the prevalence of diabetes incrementally reduces as the diet changes from
meat-based (7.6%) to vegan (2.9%) (Tonstad et al., 2009).
A second assumption was that those who self-identified “have you ever been told
by a doctor you have diabetes” were referring to type 2 diabetes. This was a reasonable
assumption because 90-95% of those with diabetes have type 2 (ADA, 2016). When a
clarification of the word “diabetes” is not given, the assumption is normally that it refers
to type 2. In addition, it is assumed type 2 since CHIP targets individuals with type 2, not
another. If CHIP participants had asked for clarification as to which type of diabetes was
meant on the pre-assessment questionnaire, they would have been told type 2. Lastly,
those with type 1 or 1.5 diabetes are often not attracted to lifestyle programs since those
types of diabetes are less associated with lifestyle and considered a progressive, lifetime
condition (ADA, 2016).
It is also assumed that all who stated they had diabetes, actually had it and that
those who did not mark it, did not have the disease. It is possible that some people who
had diabetes did not know it, and therefore did not mark the box. Others may have simply
not marked the box though they had diabetes. Lastly, it is assumed that all the biometrics
were input into the CHIP database correctly by each location director, and that the
database supplied was correct.
Many extant studies demonstrate that there are improvements in the symptoms of
type 2 diabetes when switching to a plant-based diet that excludes all animal products.
Many studies compare Adventists to other Adventists with different eating patterns, but
there are an insufficient number of studies comparing Adventists to non-Adventists with
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diabetes and their effects of switching to a plant-based CHIP diet while implementing
CHIP. A gap in the literature existed when it comes to assessing if a particular religious
belief system has an influence on biometric outcomes on those with diabetes.
Scope and Delimitations of the Study
This study design included data from 7,172 self-selected participants who had
participated in 241 CHIP programs given at 163 sites from Canada and the United States
between January 2006 and September 2012. Participants were taught and prescribed a
whole-food, plant-based diet and other healthful lifestyle principles as the intervention to
improve chronic disease biometric outcomes. Programs were facilitated mainly by
Seventh-day Adventist volunteers after having attended a two-day instruction workshop
and given all required materials to facilitate the program. The foundational treatment for
type 2 diabetes is diet and lifestyle (ADA, 2016), but literature gives little attention to
diet and lifestyle in comparison, and more attention is paid to pharmaceuticals, despite
their greater negative potential side effects over dietary changes (Graham et al., 2010;
Kannan et al., 2016; Lincoff, Wolski, Nicholls, & Nissen, 2007; Solomon &
Winkelmayer, 2007). CHIP addresses the root cause of diabetes through improving the
diet and lifestyle, which also reduces the risk of metabolic syndrome (Rankin, 2013;
Rankin et al., 2012; Morton et al., 2014b).
The only requirements for participants of the volunteer-delivered study was the
ability to pay $200-$250 for the course, attend at least 13 of 16 sessions, complete a selfreported medical questionnaire and a baseline and postintervention lifestyle
questionnaire, and have biometrics assessed, which included giving a blood sample; all
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ages were included. Participants were encouraged to join the post-CHIP support group
for further education, reinforcement, and support, but this was not a requirement.
The CHIP intervention is based on a number of theoretical frameworks, which
included the health belief model (HBM), the social cognitive theory (SCT), and the
transtheoretical model (TM). However, its foundational support comes from the theory of
planned behavior (TPB; Morton et al., 2014a), a model based upon changing attitudes of
healthy living, fostering social norms, and increasing self-efficacy (Ajzen, 2011).
Because of these strong educational components having been incorporated into the CHIP
intervention, health literacy, accountability, and perceived control improve post-CHIP
biometrics (Aldana et al., 2005). These frameworks are not investigated further in this
present study.
Limitations
Limitations are an intrinsic part of all research, which may affect the validity, and
is therefore necessary to reflect on and recognize and eliminate them in future research;
several limitations are outlined here.
1) CHIP does not have a control group in which to compare outcomes. However,
the Rockford CHIP has published research using randomized clinical control trials with
results for the professional programs showing similar outcomes as the volunteer branch
(Aldana et al., 2005a; Aldana et al., 2005b; Merrill, Taylor, & Aldana, 2008).
2) Participants attending CHIP were self-selected and therefore may be more
motivated, ready, and willing to make the necessary changes to a plant-based diet. In the
transtheoretical model of behavior change, participants may have moved from the
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precontemplation and contemplation stages and were in the preparation phase, where they
were already taking the steps to make changes (Bartholomew, Parcel, Kok, & Gottieb,
2006, p. 110-113).
3) Participants were self-identified when asked on the lifestyle evaluation, “have
you ever been told by a doctor you have diabetes"; verification was not requested. It is
possible that those with gestational diabetes, type 1 or 1.5 may have been included, but
there is no way to know. Considering that 90-95% of people who have diabetes, have
type 2 (ADA, 2016), the number of other types of diabetes would have been very
negligible. Had others been included, it would have only diluted the final results.
4) A diet diary and exercise log was not obtained from participants, so it was
unknown as to how much change or adherence there was to the diet and exercise, and the
effects those changes had on the biometrics. However, considering the positive outcomes
and assuming that all participants did not fully adapt the diet, less adherence would have
diluted the outcomes, and had there been more compliance, it would have strengthened
the outcomes.
5) An accurate medication diary was not obtained from participants throughout
the CHIP intervention, though participants informed facilitators that they had either
reduced or removed their medications by doctors order (Rankin et al., 2012). Again, had
this data been gathered, the net cause would have created a diluted effect.
6) Data was input into the CHIP online databank by the local facilitators, and it is
unknown if errors occurred during data entry. However, with 241 CHIP programs given
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at 163 sites throughout North America, it is unlikely, considering all the CHIP programs,
whether volunteer- or professional-facilitated programs, had similar outcomes.
Because this was a secondary study, further limitations and biases were minimal,
since the trial planning and trial implementation had already occurred. Bias can occur
during the planning phase of research, data collection, analysis, and publication
(Pannucci & Wilkins, 2010). Biased language (Rudestam & Newton, 2007) has been
eliminated. Known and available confounders were controlled for.
Significance of the Study
The results of this research made an original contribution to the literature by
assessing how a particular religious belief affected biometric outcomes in CHIP
participants with type 2 diabetes. The results of this study answered if the established
CHIP lifestyle education program was equally beneficial for Adventists and nonAdventists alike for those with diabetes. Adventists are known for their healthful,
baseline lifestyles and reduction in diabetes over their non-Adventist counterparts
(Alexander, Lockwood, Harris, & Melby, 1999; Fonnebo, 1992). By giving all
participants the tools they need to start and maintain a positive healthy lifestyle and
teaching its benefits, the positive social change from this study showed that the Adventist
health message, as presented through CHIP, is an effective non-medical, whole-food,
plant-based, lifestyle model in improving type 2 diabetes outcomes for all people,
regardless of their Adventist status. The Adventist health message is a source of
inspiration, optimism, strength, and guidance for many people with diabetes who desire
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to control, prevent, or reverse this disease through a non-medical, nonpharmaceutical
lifestyle approach.
Summary
Chapter 1 introduced the health challenges and the financial impact of type 2
diabetes in the United States and its association with a nonvegetarian diet. A diet
consisting of whole plant foods reduce the risk of diabetes while animal products increase
the risk, and as the diet moves more towards vegan, the lower the risk of diabetes
(Tonstad et al., 2013). As a plant-based program, the CHIP community program given by
Adventists has the potential of influencing large numbers of people, and when
incorporated, reduces risk factors for chronic disease (Rankin et al., 2012).
This research incorporated the social ecological model (Bronfenbrenner, 1979) to
explain the influence, interconnectedness, fluidity, and complex associations that occur
among and between the social groups: individual, interpersonal relationships, the
community, organizations, and the society at large. This study assessed if there was a
statistically significant difference in the change in biometric outcomes (TC, HDL, LDL,
TG, FPG, SBP, DBP, and BMI) between Adventists and non-Adventists with selfidentified diabetes pre- and post-CHIP between January 2006 and September 2012. It
also assessed if there was a statistically different self-identified diabetes prevalence rate
in Adventists and non-Adventists preprogram. The nature of this study was a quantitative
secondary data analysis collected from 241 program sites between 2006 and 2012
involving 7,172 graduates. The knowledge gap and potential contribution has been
addressed. Per CHIP research, the Adventist health message has been an effective
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nonmedical, whole-food, plant-based, lifestyle model in improving type 2 diabetes and
other chronic diseases.
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Chapter 2: Literature Review
Introduction
Type 2 diabetes and its precursor, prediabetes, have substantial implications for
general and individual overall health and life expectancies, U.S. federal and state health
care costs, household budgets, and employer costs. By 2020, an estimated 52% of the
United States adult population will have either prediabetes or diabetes, up from 40% in
2010 (United Health Center for Health Reform & Modernization, 2010). At the time of
this study, diabetes was the seventh leading cause of death in the United States (CDC,
2013a).
Type 2 diabetes has significant financial and medical costs. Persons with diabetes
on average spend 2.3 times more money on healthcare and have 2.9 times more doctor
visits than their counterparts who do not have diabetes (Dall et al., 2010). Persons with
diabetes also require more hospital admissions, home health visits, emergency room
services, prescription drugs, medical supply needs, and use of nursing homes (Dall et al.,
2008). Over 81% of people with diabetes take some kind of diabetes medication (CDC,
2013b). They also lose between 3.3 and 18.7 years of life, while incurring higher lifetime
health care costs, from $8,946 to $159,380 more, depending on age at diagnosis,
ethnicity, and gender (Leung, Pollack, Colditz, & Chang, 2015).
Many studies have shown lifestyle approaches to be cost-effective (Eriksson et
al., 2010; Jacobs-van der Bruggen et al., 2009) while reducing medication use (Englert,
Diehl, Greenlaw, & Aldana, 2012). Several lifestyle programs exist that address
preventing and controlling diabetes, including the Complete Health Improvement
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Program (CHIP; Diehl, 1998), the focus of this study. CHIP is a multifactorial lifestyle
educational program focused on diet, exercise, and stress reduction for the purpose of
improving health outcomes for chronic diseases including diabetes, coronary artery
disease (CAD), and hypertension (Diehl, 1998; Rankin et al., 2012). CHIP was initially
based on the theory of planned behavior, and as a result included a strong educational
component designed to improve health attitudes, promote healthy social norms through
support groups, and improve perceived control through self-efficacy (Kent et al., 2014).
Literature Search Strategy
The literature search for this dissertation was a comprehensive search using
Walden University’s online library system to identify articles, using the following
databases: Academic Search Complete, PubMed, and CINAHL & MEDLINE
Simultaneous Search. Search terms included key words with no limit in years and found
anywhere in the text, title, or abstract of the article. The journal articles were peerreviewed and reviewed in either full text or abstract format. The following keyword
searches yielded highly variable results: Complete Health Improvement Program (8),
Coronary Health Improvement Project (46), Adventist (3,929), type 2 diabetes and vegan
diet (235), vegetarian diet (909), type 2 diabetes and lifestyle medicine (82), Hans Diehl
(86), D. Ornish (120), Pritikin (10), and lifestyle intervention and diabetes (5,614). Other
articles were found using the snowball effect, and through informal conversations with
researchers to locate articles that were in-press but had not yet been published. The article
selection excluded research on institutionalized subjects and women with gestational
diabetes, while including research on both U.S. and international participants.
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Conceptual Framework
This study used the Social Ecological Model (SEM) framework to evaluate the
effect of the Adventist health message as taught through the CHIP intervention. The SEM
was designed to promote health by focusing on the social accumulated effects of five
social influence levels (Raingruber, 2014): interpersonal relationships, intrapersonal
relationships, community, institution, and societal influences, all of which have a
combined and cumulative effect on an individual. People succeed by having a supportive
social environment at every level; the model assumes that each social environment
influences human behavior accumulatively.
SEM has been used in a variety of public health settings, with the most notable
ones being Mothers Against Drunk Driving (MADD) and Students Against Driving
Drunk (SADD; DeJong et al., 1998). Over a period of 25 years, MADD changed an
entire country’s perception about drunk driving by targeting individuals and peer-related
relationships, forming community chapters, pressuring lawmakers to pass tough criminal
laws, and using media to reinforce their message (DeJong et al., 1998). Intervening on
behalf of a drunken person and choosing a designated driver have both become socially
acceptable messages (DeJong et al., 1998). The SEM has also been used to assess
drinking patterns in a variety of settings, from home to bars, pubs, restaurants, and
friend’s or relative’s home, as well as appraising the impulse to drink more (Gruenewald,
Remer, & LaScala, 2014).
Schwartz, Tuchman, Hobbie, and Ginsberg (2011) broadened the traditional
SEM, building a model for guiding chronically ill adolescents and young adults to
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transition easier into adult health care. The new model incorporates pre-existing
constructs, such as health care access, sociodemographics, medical status and risk, and
IQ, as well as modifiable subjective variables, such as knowledge, goals, beliefs and
expectations, skills and efficacy, relationships, and psychosocial functioning of all
stakeholders involved (the patient, providers, and parents). This inclusion of additional
stakeholders was intended to facilitate other clinicians and investigators building
evidence-based evaluation tools to help make an optimal transition for chronically ill
young adults.
The SEM has also been used for several other contexts. Dunn, Kalich, Henning,
and Fedrizzi (2015) used focus groups based on the five social levels of the SEM to
understand the multifaceted barriers and contributing factors for breastfeeding in lowincome women. Barriers at each social level were then turned into educational
opportunities to support breastfeeding, which ranged from teaching new mothers and
family the importance of breastfeeding, to placing a baby-friendly hospital initiative, to
implementing new workplace policies. Baral, Logie, Grosso, Wirtz, and Beyrer (2013)
used the five social levels of the SEM to characterize the multilevel risks of HIV
infection, turning each risk level into an evidence-based behavioral and structural
intervention. As is characteristic of the SEM, each social level was found to be fluid and
interactive with each other social level.
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Literature Review
Type 2 Diabetes
Diabetes is a chronic, progressive disease characterized by high blood sugars
caused by either a lack of insulin or inefficient use of the insulin by the body (ADA,
2016). The most common form of diabetes is type 2, which traditionally occurred in older
people but now has been found to occur in younger people of any age (ADA, 2016).
Approximately 29.1 million people in the United States already have type 2 diabetes;
approximately 1.7 million people in the United States acquire the disease annually (ADA,
2013). Type 2 diabetes kills almost 74,000 people annually in the United States and costs
the U.S. national healthcare system billions of dollars per year (ADA, 2013).
Since 2002, the annual total economic cost of diabetes in the United States has
risen from $132 billion (ADA, 2003) to over $245 billion in 2012 (ADA, 2013). Seventy
percent of people with diabetes will die from cardiovascular disease (CVD), which
includes heart disease, their number one cause of death and disability (Zhao et al., 2014).
CVD costs are projected to triple from $273 billion in 2010 to $818 billion in 2030
(Heidenreich et al., 2011). Coronary heart disease (CHD) takes the life of 380,000 people
annually at a cost of $108.9 billion, causing about 720,000 heart attacks each year
(Murphy, Xu, & Kochanek, 2013).
Some of the current, well-recognized risk factors of type 2 diabetes include the
following:
•

being overweight (Biggs et al., 2010)
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•

inactivity (Hu, 2003; Jeon, Lokken, Hu, & van Dam, 2007; Plotnikoff,
Costigan, Karunamuni, & Lubans, 2013)

•

improper nutrition (Barnard et al., 2009a; Pan et al., 2011; Tonstad et al.,
2013)

•

high blood pressure, cholesterol, and blood sugars (ADA, 2016)

Complications of diabetes include cardiovascular disease, albuminuria,
hypertension, dyslipidemia, poor healing, retinopathy, neuropathy, erectile dysfunction,
peripheral artery disease, and foot complications (ADA, 2016). Major risk factors for
type 2 diabetes includes ethnicity, being 45 years old and older, having a BMI of 25
kg/m² or greater, and being on certain medications (ADA, 2016). Diabetes and its
complications are both considered insidious and progressive by Western medicine
standards (ADA, 2016), and treatments include limited lifestyle education, oral
medications, and insulin (ADA, 2016). However, on a plant-based, whole-food diet
without the use of animal products, and exercise, this disease can be reversed and
prevented (Le & Sabate, 2014).
The precursor to diabetes is the metabolic syndrome, a cluster of symptoms
related to an increased risk of CVD, microvascular complications, and stroke (ADA,
2016). CVD is accompanied by hypertension and dyslipidemia, and it is the major
morbidity and mortality event contributing to the high costs of diabetes treatment (ADA,
2013). Metabolic syndrome is characterized as having three of five risk factors according
to the “harmonized definition” as set forth in 2009 by a joint effort among the
International Diabetes Federation Task Force on Epidemiology and Prevention; the
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National Heart, Lung, and Blood Institute; the American Heart Association; the World
Heart Federation; the International Atherosclerosis Society; and the International
Association for the study of Obesity (Alberti et al., 2009). These interrelated risk factors
include central obesity, hypertension, raised TG, low HDL, and dysglycemia. These
factors occur together routinely and are present in most people with type 2 diabetes.
The harmonized definition for the criteria diagnosing metabolic syndrome
includes the following:
1)

Elevated waist circumference that is population and country specific

2)

TG ≥150 mg/dL (1.7 mmol/L)

3)

HDL <40 mg/dL (1.0 mmol/L) for males and <50mg/dL (1.3 mmol/L) for
females

4)

SBP ≥130 and/or DBP ≥85 mmHg

5)

FPG ≥100 mg/dL

In order to categorize these and all data variables, CHIP used the conventional
risk factor categories set up by the NCEP Adult Treatment Panel III classification system
(Panel, NCEPNE, 2002) except for TC, for which it used the Framingham risk
classification (Wilson et al., 1998). The Framingham risk classification allowed for five
categories of classification, and a more detailed analysis, instead of three categories that
the NCEP used (Rankin et al., 2012). Classifications for each biometric for this current
research are categorized as listed:
TC (mg/dL): <160; 160-199; 200-239; 240-280; >280
HDL (mg/dL): <40; 40-60; ≥60
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LDL (mg/dL): <100; 100-129; 130-159; 160-190; >190
TG (mg/dL): <100; 100-199; 200-500; >500
FPG (mg/dL): <110; 110-125; >125
SBP (mm Hg): <120; 120-139; 140-160; >160
DBP (mm Hg): <80; 80-89; 90-100; >100
BMI (kg/m²): <18.5; 18.5-24.9; 25-30; >30
Early Health History
Health reformers point out that a healthy, active lifestyle and a plant-based diet
have been around for millennia; these are not new concepts or fads in disease prevention,
as many believe (Sabate, Ratzin-Turner, & Brown, 2001). Plant-based diets and timeless
lifestyle principles have been intuitively taught and prescribed since the time of
Hippocrates, and later studied for their effectiveness; they continue to be researched
today (Schwarz & Greenleaf, 2000). Hippocrates (460 BC-370 BC) was a Greek
physician known as the “father of modern medicine,” and his timeless Hippocratic Oath
articulates the medical ethos of “do no harm.” Historically, this has been an oath taken by
physicians (Copland, trans. 1825; Karagiannis, 2014). In addition, Hippocrates is known
for his proverb, “let food be thy medicine and thy medicine be thy food.” He understood
and taught the connection between disease and lifestyle, the causation of illness, and
ageless principles of health as written throughout the Hippocratic corpus (Karagiannis,
2014). Another well-known, early health reformer was Sylvester Graham, a Presbyterian
minister, best known for his creation of coarse graham bread and the graham cracker, all
originally made without additives and chemicals, and minimally processed (Graham,
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1835, 1837). He also emphasized vegetarianism, the elimination of tea and coffee, and
abstinence in order to properly nourish the body for disease prevention (Wendell, 1835).
Comprehensive health reform contemporaries to Graham were William Alcott,
who founded The American Vegetarian Society (Robinson, 1965), and Joseph Bates, a
seaman and early pioneer of the Seventh-day Adventist movement in 1839. He organized
a temperance society and advocated for discarding coffee, tea, meat, butter, cheese, pies,
and rich cakes in order to preserve health and prevent disease. John Harvey Kellogg,
another early Adventist health reformer most notably known for his Kellogg’s breakfast
cereal, advocated for coffee and tea substitutes, vegetarian health reform (Robinson,
1965), and tobacco cessation (Kellogg, 2002). He also helped start holistic Battle Creek
Sanitarium where he became the chief physician in 1876 under the encouragement of
Ellen G. White, another early Adventist pioneer who progressively began to understand
the connection between mind, body, health, diet, and worship (Robinson, 1965).
Beginning in 1863, White became the most outspoken Adventist health reformer,
advocating for not only a vegetarian diet and abstinence in coffee, tea, alcohol, and
tobacco, but advanced the health reform cause by encouraging a plain, wholesome 2meals per day diet that eliminated swine flesh. White also advocated dress reform,
exercise, cleanliness of self and surroundings, trust in God, fresh air, proper nightly and
weekly rest, moderate sunshine, and water as treatment modalities over medications
(Robinson, 1965; Schwarz & Greenleaf, 2000). White, who claimed her knowledge came
from God, went on to become the most translated American author in history, influencing
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millions worldwide on a variety of important topics, all with only a third-grade education
(White, 2000). Her work is discussed in further detail later.
Since the startup of Battle Creek Sanitarium, other non-Adventist current-day
health reformers validate these health principles, such as Nathan Pritikin, founder of the
Pritikin Longevity Research Institute in 1976, and John A. McDougall, founder of
McDougall’s Health & Medical Center in 2002, have incorporated into their own practice
health principles similar to the ones espoused by Ellen White. Pritikin, an engineer and
inventor, was found to have heart disease at 40 years old but reversed it through a very
low-fat, high-fiber, low-cholesterol, mainly plant-based diet and exercise, and then
marketed it to others through his own program (Morton et al., 2014a). An autopsy upon
Pritikin’s death 27 years later showed no signs of heart disease (Hubbard, Inkeles, &
Barnard, 1985). While working at Pritikin’s residential center, and seeing cost as a
limitation for attendees, Hans Diehl became inspired to start the CHIP program, the
program of focus for this current research. This Adventist-facilitated program cost less,
and participants did not have to leave home, making it well accepted and attended
(Morton et al., 2014b).
Over 100 research articles have been published on the Pritikin diet. Pritikin’s
research revealed that the diet led to a 37% reduction in meeting metabolic syndrome
criteria, a 3% BMI reduction, a 12-15% reduction in FPG and LDL respectively, a 15%
reduction in TC, a 36% reduction in TG, and a 3% reduction in HDL after a 12-15 day
residential stay (Sullivan & Klein, 2006). The limitations in this study were that it was
retrospective and not randomized with controls, the patients were highly motivated, and
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longer-term results needed follow up. After a 26-day program, FPG dropped from 178 to
134, 77% discontinued oral hypoglycemic agents, 72% discontinued insulin, and one was
placed on insulin. After a two and three year follow up FPG remained similar, but 40%
restarted oral agents and 22% restarted insulin, with the calories from fat being the
difference in adding back the medication (Barnard, Massey, Cherny, O’Brien, & Pritikin,
1983).
Just as Pritikin sought to treat his own CVD through diet, so did John McDougall,
MD. Through his diet, he successfully reversed the effects of a massive stroke he
experienced, which had left him paralyzed on the left side for 2 weeks (McDougall,
2001). Between 2002 and 2011, 1,615 patients attended McDougall’s residential
program, and after seven days in the program there was a reduction in CVD risk from
7.5% to 5.5% (McDougall et al., 2014). Participants also showed significant health
improvements in FPG, blood pressure, and lipid levels; 19%, 14% and 20% of
participants reduced their SBP, DBP, and TC to normal, respectively. McDougall also
published the first study, though small, on improving prognosis for breast cancer through
a plant-based diet, which reduced cholesterol by 16%, prolactin by 38%, estrogen by
37%, and estradiol by 45% (McDougall, 1984).
Neal Bernard, a psychiatrist and founder of Physicians Committee for
Responsible Medicine, has written approximately 17 books to date and routinely authors
research articles linking health and nutrition (Barnard et al., 2014a; Barnard, Levin, &
Trapp, 2014b; Bunner, Agarwal, Gonzales, Valente, & Barnard, 2014). When comparing
a vegan, plant-based diet to the diet recommended by the ADA for 74-weeks (Barnard et
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al., 2009a) and 22-weeks (Turner-McGrievy et al., 2008), Barnard and his colleagues
found that both diets were well accepted and adhered to, but the vegan diet led to a
greater improvement in macronutrients intake, glycohemoglobin A1c (HgbA1c) and
plasma lipids, while reducing the need for more medications (Barnard et al., 2009a).
A 22-week worksite study with 109 employees with either diabetes or who were
overweight found that that a vegan diet improved all health-protective nutrients and
reduced TC and saturated and total fat, though LDL and TC differences were not
statistically significant (Levin et al., 2010). Those on the vegan diet lost significantly
more weight and reduced their BMI (Levin et al., 2010), and those in the intervention
group experienced greater improvements in mental health, diet satisfaction, and physical
health (Katcher, Ferdowsian, Hoover, Cohen, & Barnard, 2010).
Lifestyle Medicine
Lifestyle medicine is an evidence-based, clinical discipline focusing on the
prevention, management, and treatment of disease through lifestyle changes such as diet,
exercise, stress management, tobacco discontinuance, rest, alcohol reduction, and a
variety of other nonmedical modalities (American College of Lifestyle Medicine, n.d.;
American College of Preventive Medicine, n.d.). A healthy lifestyle is the first line of
defense for many chronic diseases (Fraser, 2009), and while a call for uniformity in this
practice has been attempted to help physicians feel more confident (Lianov & Johnson,
2010), many believe they are still ill equipped to counsel on such topics (Dacey,
Arnstein, Kennedy, Wolfe, & Phillips, 2013; Lianov & Johnson, 2010). “Lifestyle should
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be the foundation of our healthcare system” but is not covered by insurance, so is not
included in most physician practices (Hyman, Ornish, & Roizen, 2009, p. 12).
The American College of Lifestyle Medicine (2012) described CHIP (Rankin et
al., 2012) as “yielding some of the most impressive recorded clinical changes ever in the
literature. The results were achieved by volunteers, making this a most cost effective
model for combating chronic disease.” Several other historical studies and pioneers
highlight the effectiveness of lifestyle medicine.
Lifestyle Programs
Since the mid-1950s, longitudinal studies have begun to reveal associations
between incidence, prevalence, predisposing factors, and prognosis between lifestyle and
diet in type 2 diabetes; these long-term studies include the following:
• the Framingham Study (Castelli et al., 1986)
• the Nurses’ Health Study I and II (Belanger, Hennekens, Rosner, &,
Speizer, 1978; Pan et al., 2011)
• Health Professional Follow-Up Study (Pan et al., 2011)
• the Adventist Health Study 1 and 2 (Rizzo, Sabate, Jaceldo-Siegl, &
Fraser, 2011; Tonstad et al., 2009; Tonstad et al., 2013)
• Adventist Mortality Study (Vang, Singh, Lee, Haddad, & Brinegar, 2008)
In addition, live-in, residential lifestyle programs provide a controlled setting
where participants learn to optimize their diet (McDougall et al., 2014, Slavicek et al.,
2008). However, the live-in approach is expensive for some, and participants must leave
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home and work to attend the program, only to return home to what is often minimal
psychosocial support.
An alternative to live-in, residential lifestyle programs are those that teach
lifestyle principles in a classroom setting, instructing patients how to manipulate diet and
lifestyle factors to reduce the risk or the prevalence of chronic diseases like diabetes or
methods of controlling or reversing them. Examples of research using vegan, plant-based
interventional programs include the following:
•

workplace research (Levin et al., 2010)

•

randomized, controlled studies (Barnard et al., 2009a)

•

the Diabetes Prevention Program’s clinical trials comparing diet to
pharmaceuticals (Knowler et al., 2002)

•

private physician offices (Crowe, Ellis, Esselstyn, & Medendorp, 1995;
Esselstyn, 1999)

Many studies have shown the benefit of lifestyle approaches to be cost-effective
and offer good value for the money (Bertram, Lim, & Barendregt, 2010; Eriksson et al.,
2010; Jacobs-van der Bruggen et al., 2009).
Clinical Health Programs
In addition to the residential lifestyle centers, current private practice practitioners
such as surgeon, Caldwell Esselstyn, and Dean Ornish, also got involved in health reform
teaching a plant-based diet without the use of animals. Results from research on 22 of
Esselstyn’s patients with severe CAD revealed that after 10 years, CVD had been arrested
with no new myocardial infarctions for the 11 who remained on the interventional, plant-
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based, low-fat diet (Crowe et al., 1995). Of the other 11 patients, six dropped out but
remained on the diet without further cardiac events, the remaining five dropouts who
returned to their original diet suffered a total of 10 cardiac events. Another study
(Esselstyn & Golubic, 2014b) presented three case histories of patients with advanced
heart disease progression who had been treated with the normal standard of care of
multiple surgeries and medications, yielding unsatisfactory results. After switching to a
whole-food, plant-based diet and removing animal products, each markedly and promptly
improved. Another group of 177 patients reported similar results (Esselstyn, Gendy,
Doyle, Golubic, & Roizen, 2014).
Ornish published over 40 research articles on his plant-based comprehensive
lifestyle program (Ornish, n.d.). He published the first randomized clinical trial to
evaluate the progression of atherosclerosis without drugs, instead prescribing a plantbased diet and lifestyle (Ornish et al., 1983; Ornish et al., 1990; Ornish et al., 1998).
Compared to the control group, after 24 days, for the group that adhered to the diet, the
frequency of angina episodes intervention was reduced by 91% and cholesterol by 21%
(Ornish et al., 1983). Sixty-one percent of participants reported no chest pain after 3 years
of continuing to be on the program at an average cost difference between $18,119 for the
intervention group and $47,647 for the control group (Ornish & Multicenter Lifestyle
Demonstration Project Research Group, 1998).
In a study of 24 sites with 2,974 men and women, the Ornish program evaluated
participants at baseline, after 24 weeks, and 12 months to evaluate longer-term results
(Silberman et al., 2010). Of the 78.1% (n=2,322) who remained enrolled in that program
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after one year, significant improvements in both subjective and CVD risk factors were
seen in glycohemoglobin A1c (HgbA1c), BMI, LDL, TC, SBP, DBP, and TG; HDL
remained unchanged. Due to the success of these comprehensive lifestyle programs, as of
September 2010, Medicare reimbursed for both the outpatient Ornish program and the
residential Pritikin program (Harvard Health Letter, 2010).
Long-Term Studies in Lifestyle
Epidemiological studies, with a focus on disease prevention, partnership, disease
risk factor identification, disease surveillance, and disease cause and effect, are the
cornerstones and guides of public health decisions and evidence-based practice
(Blumenthal, & Yancey, 2004). Some of the first epidemiological studies were the
infamous Tuskegee Syphilis Study (1932-1972; Roy, 1995) and the Framingham Heart
Study (1948-present; Mahmood, Levy, Vasan, & Wang, 2014). In 1954, the Adventists
began a progressive series of longitudinal, cohort studies:
•

Adventist Mortality Study (AMS; 1958-1966)

•

Adventist Health Study-1 (AHS-1; 1974-1988)

•

AHS-2 (2002-present), and their sub-studies

•

Adventist Health Air Pollution Study (1976-present)

•

Adventist Religion and Health Study (2006-present; Loma Linda
University School of Public Health, 2015a)

Other well-known non-Adventist, key epidemiological studies include the China-CornellOxford Project I and II (the China Study I [1983-1984] and II [1989-1990]), and the
Nurses’ Health Study I and II (1976 and 1989).
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The Framingham Study followed 5,209 adults from Framingham, Massachusetts
to understand cardiovascular disease. The study was inspired by health concerns after
President Franklin Roosevelt (1882-1945) died from CVD (Mahmood et al., 2014). Out
of this research came the Framingham risk scores, a 10-year prediction of cardiovascular
risk development, which shifted the focus of CVD from treatment to prevention (Rodondi
et al., 2012). With over 1,000 published medical articles, this study clearly shows an
association between diet, lifestyle, and disease (Millen & Quatromoni, 2001; Millen et
al., 2005; Millen et al., 2006; Posner et al., 1995; Wolongevicz et al., 2010).
The China Study surveyed 6,500 people in 130 rural villages in China, examining
the correlation between animal products and chronic disease such as diabetes, coronary
artery disease (CAD), and certain cancers (Campbell, Parpia, & Chen, 1998). Campbell
found that the greater the proportion of plant foods in the diet, the fewer chronic diseases,
and that there was no point at which further reduction of animal products did not help.
Rural China participants on average consumed a diet low in animal products and high in
plant foods, which consisted of half the fat and three times the fiber than what Americans
consume; 90% of their protein came from plants. Americans on average have a diet that
is 30-45% fat; American men have a 16.7-fold increase in mortality rate over their
Chinese counterparts, and American women have a 5.6-fold increase (Campbell & Chen,
1999).
The Nurses’ Health Studies (NHS) has yielded over 1,400 studies (National
Health Sciences, n.d.) following 121,700 female nurses in NSH-1 and 116,671 female
nurses in NSH-2 since 1976 and 1989, respectively (Pan et al., 2011). The NHS indicates
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a clear correlation between meat consumption, other dietary factors and type 2 diabetes
(de Munter, Hu, Spiegelman, Franz, & van Dam, 2007; Devore et al., 2009; Fung,
Schulze, Manson, Willett, & Hu, 2004; Fung, McCullough, van Dam, & Hu, 2007; Jiang
et al., 2002; Pan et al., 2011; Schulze et al., 2004; Schulze et al., 2005; Sun et al., 2010;
Wedick et al., 2012).
Adventist Health Movement History
A worldwide, growing body of about 18 million members, the Seventh-day
Adventist church is a conservative Protestant movement that believes the Christian
experience is meant to pervade the whole life, emulating the gospel ministry and health
ministry of Jesus (Seventh-day Adventist World Church, 2015a). Though they officially
established themselves as a church in 1863, they have been meeting and growing since
the 1840s (Seventh-day Adventist World Church [SDAWCH], 2015b). Since its
inception, their movement has been based on health outreach, with now well over 75,000
churches, 21 vegetarian-focused food industries, 175 hospitals and sanitariums, 136
nursing homes and retirement centers, 269 clinics and dispensaries, 34 orphanages and
children’s homes, and 10 airplane and medical launches, located in 216 of the 238
countries around the world (SDAWC, 2015b).
Founded by the Adventist church in 1956, their largest health and humanitarian
outreach program is the Adventist Development and Relief Agency (ADRA), a leading
nongovernmental organization (NGO) stationed throughout 125 countries (ADRA, n.d.).
ADRA provides health promotion, humanitarian relief, food distribution, and disaster
relief in times of disaster and for long-term development for those in poverty and distress.
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The focus of their worldwide work is to promote health, provide food and water, protect
the vulnerable, support families, help establish livelihoods, and respond to emergencies.
Their second largest faith-based health outreach program is the Adventist Health System
(AHS), operating 8,100 licensed beds within 45 hospitals in 10 U.S. states, seeing more
than 4.5 million patients per year (Adventist Health System, n.d.). The church also
operates urgent care centers, hospice care, home health care, and skilled nursing facilities.
In line with keeping their health vision, one of the Adventist’s 28 fundamental
beliefs includes believing that the key to wellness lies in temperance and health reform,
as well as keeping the body free from alcohol, tobacco, mind-altering substances, and
other harmful chemicals (Ministerial Association, General Conference of Seventh-day
Adventists, 2005). The Adventist health message also includes promoting clean, healthy
lives through the intake of fresh air, pure water, moderate sunlight, daily exercise, one
day weekly and nightly rest, trust in God, moderation of all things healthful, and a diet
abstaining from meat but including legumes, nuts, grains, fruits, vegetables, and a source
of B-12 (Seventh-day Adventist World Church, 2015c).
The Adventist’s message of health started as early as 1848 when Ellen G. White
(1827-1915) spoke out about the harmful effects of coffee, tea, and tobacco (White,
1870). Progressively through her years, she presented new dietary and non-dietary health
principles, as the denomination was able to accept more changes (Douglass, 1998,
Emergence of a Health Message). Compilations of her decades-long messages of
healthful living, reside under several titles but most notably, in Counsels on Diet and
Foods (White, 1938). Other more-current healthy-living titles include Counsels on Health
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(1923), Ministry of Healing (1905), Temperance (1949), and Medical Ministry (1932),
some of them compiled after her death, with some original titles and full books adopting
more modern titles.
White began to understand the relation of physical health to spirituality in 1863,
and continued educating the church until the time of her death in 1915 (Douglass, 1998,
Reviewing A Century of Health Reform Principles). Though many of these health
principles are taught in modern days as a matter of fact and integrally related, in her day
her views collectively were extreme (Douglass, 1998). The CHIP intervention and
White’s principles share a similar healthful foundation. With only a third grade
education, who claimed her message came from God, White’s health message (White,
1938) included the following:
•

Obeying the natural laws of health will prevent many illnesses

•

Turning towards a healthy diet will help reverse diseases; improper eating is
a cause of disease

•

Tobacco, coffee, tea, alcohol, and wine are slow poisons

•

Freely eat of fresh fruits and vegetables

•

Eat nuts in moderation. Some nuts are more healthful than others such as
almonds are more healthful than peanuts.

•

Drinking plenty of pure fresh water will help maintain health and cure many
illnesses

•

The flesh of swine is never to be eaten

•

Outdoor exercise is healthful for mind and body
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•

Overworking breaks down the body

•

Overeating is intemperate

•

Temperance and moderation in all things healthful

•

Many people die prematurely solely from eating animal flesh foods and
should not be eaten

•

Caring for the body is a spiritual commitment to God

•

Fasting provides curative powers

•

A time will soon come when eating dairy, cream, eggs, and butter will be
unhealthful due to the increase disease of animals

•

Cleanliness of the home and body is important

•

Do not drink beverages including water with meals

•

Eat more raw foods and fewer cooked foods

•

Eating between meals is injurious to the stomach and digestive system

•

Eating two meals per day is better than three but if a third meal is taken in the
day, it should be easily digestible and light, and should be taken several
hours before bedtime. Adequate time between meals are necessary for proper
digestion.

•

Rich cakes, pies, and puddings are injurious, as is the combination of sugar
and milk

•

Those who are used to a meat-based diet will not at first relish a more simple
diet; adjustment takes time.
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•

Pickles, vinegar, spices, baking soda, baking powder, lard, cheese, grease,
and too much salt are harmful

Adventist-Related Research
Adventists have been involved in health education since its inception in the
1840s, educating both its members and the public (Robinson, 1965; Schwarz &
Greenleaf, 2000). In 1954, Adventists entered the field of epidemiological research, and
since then have published hundreds of peer-reviewed research articles (Hardinge & Stare,
1954a; Hardinge & Stare, 1954b). Adventists have participated in five large, longitudinal
studies all based out of Loma Linda, California: AMS (1958-1966), AHS-1 (1974-1988),
Adventist Health Air Pollution Study (1976-present), AHS-2 (2002-present), and
Adventist Religion and Health Study (2006-present), all focusing on the different aspects
of relationship between diet, lifestyle, and disease (Lee et al., 2009; Loma Linda
University School of Public Health, 2015b). Adventists have proven that they are quite
willing to participate in health research studies.
Adventists are an ideal group to study since by proscription for over 160 years,
nearly all abstain from smoking (98.9%) and alcohol (95.4%), thereby reducing the
confounding effects of these nondietetic factors (Butler et al., 2008). Adventists also
abstain from biblically unclean meats such as fish without fins and scales, pork, and
shellfish (Leviticus 11) and are encouraged to abstain from caffeinated beverages, tea,
rich desserts, highly refined foods, and spices. Moreover, Adventists advocate exercise
and a vegetarian diet high in fruits, vegetables, nuts, and grains—though a vegetarian diet
is not required (Phillips et al., 1980). A wide array of diets are practiced among this
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group; the percentages may slightly vary from study to study, but generally the earlier
studies reported Adventists were 4.2% total vegetarian or vegan, 31.6% lacto-ovo
vegetarian, 11.4% pesco-vegetarian, 6.1% semi-vegetarian (having meat fewer than one
time per week), and 46.8% not vegetarian (Butler et al., 2008). Partly as a result of diet
and exercise, the earlier the age of baptism into the church, the lower the relative rate
(RR) of death (Snowdon et al., 1982); for those baptized as children as compared to
adults, the RR of ischemic heart disease death was 0.71, with reduced mortality rates for
men but not women (Heuch et al., 2005).
The AMS was the first major Adventist research study raising awareness to the
link between diet and health, enrolling 22,940 Californians (Phillips, Lemon, Beeson, &
Kuzma, 1978) with a 5- and 25-year follow up. Compared to the American Cancer
Society (ACS), a group being researched at the same time as the AMS with similar
education and incomes, Phillips et al. (1980) reported a lower mortality ratio in
Adventists for all-cause cancers (males 0.60, females 0.76), all-cause deaths (males 0.66,
females 0.88), coronary heart disease (males 0.66, females 0.98), and most cancers.
However, despite the improved outcomes for diabetes, most cancers (breast, ovaries,
colon, ovaries, rectum, and prostate), and vascular diseases, male Adventists had a higher
ratio in stomach cancer (1.41) and women had an equal ratio in lymphoma and leukemia
(1.00), as well as higher nonspecific circulatory conditions (1.01) than the ACS group.
Comparing cancer risk of California Adventists with that of the general California
population, many results were even better in outcomes for diabetes, vascular disease, and
cancers than those from the ACS studies (Phillips, 1980). This new knowledge in the
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AMS brought up further questions regarding what specifically was it about the Adventist
lifestyle that allowed them to live longer, which led into AHS-1 (Beeson, Mills, Phillips,
Andress, & Fraser, 1989).
AHS-1 was designed to discover which aspects of the Adventist lifestyle provided
the disease protection found in the AMS (Beeson et al., 1989). Baseline data for the
AHS-1 included 34,198 non-Hispanic Adventist California Caucasians, where 55.2%
were ovo-lactovegetarian or vegan, 6% ate meat daily [Snowdon, 1988], and 50% were
converts not born into the church; researchers were able to follow up with 98.8% of the
participants over 12 years (Beeson et al., 1989). A meta-analysis of five prospective
studies, which included the AHS-1 and AMS, revealed that vegetarians had lower rates of
death from heart disease (0.76 average) and mortality from any cause (0.95). Further, the
vegetarians had lower cholesterol and BMI, less tobacco and alcohol use, and exercised
more than nonvegetarians (Key et al., 1998). Eating nuts at least four times per week also
reduced the risk of CHD by 37% (Kelly & Sabate, 2006). Overall, the survival advantage
of California Adventists comparing vegetarians to nonvegetarians was 3.6 years of
additional life in one study (Singh, Sabate, & Fraser, 2003) and 7.28 years longer in men
and 4.42 years for women in another study (Fraser & Shavlik, 2001). Longevity in
Adventists has been known since 1969, when Lemon and Kuzma (1969) reported a 6.2year greater life expectancy in California Adventist men and 3.7 years for California
Adventist women than the life expectancy of the general U. S. population.
In 1977, researchers expanded the AHS-1 and began investigating the long-term
effects of air pollution on health outcomes such as CHD, all-cause mortality, and newly
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diagnosed cancers, as well as the symptoms of emphysema, bronchitis, and asthma. The
majority of Adventists do not smoke (98.2%), which reduces distortion when doing this
kind of study (Beeson et al., 1989).
The AHS-2 recruited over 96,000 Adventists from the United States and Canada,
making it the largest prospective study of its kind (Butler et al., 2008), and includes the
largest study on African Americans (Herring, Butler, Hall, Montgomery, & Fraser, 2010).
They sought to answer a number of questions: Is heredity or lifestyle more important?
Does faith influence health outcomes? Which foods prevent diseases such as
Alzheimer’s, cancer, diabetes, arthritis, and heart disease? Which foods improve quality
of life? In addition, why do African Americans have disproportionate numbers of heart
disease and cancers? In the AHS-1 group (Butler et al., 2008), 8% are vegan compared to
2% of the general population (Gallup, 2012), 28% are lacto-ovovegetarian compared to
5% of the general population (Gallup, 2012), 16% are either pescovegetarian or
semivegetarian, and 48% are nonvegetarian.
Compared to nonvegetarians, the AHS-2, AHS-1, and AMS combined found
vegans had 5 points lower BMI, 75% less risk of hypertension, between 47% and 78%
lower risk of diabetes, 14% less risk of all-cancer, but had a 73% increase risk of urinary
tract cancer, 42% lower risk in CVD mortality, and 55% lower risk for ischemic heart
disease (IHD; Le & Sabate, 2014). Le & Sabate (2014) also found that the dietary habits
of Adventists contain more fiber than the average intake, and those that do eat meat,
consume less than the average intake. Diet reduces the risk of many health disparities but
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does not account for all. In addition to diet, socialization and religion have also been
predictors of longevity—hence, the Adventist Religion and Health Study.
The Adventist Religion and Health Study is a subset of the AHS-2 group
consisting of 11,000 United States and Canadian Adventists, which set out to determine
which aspects of religion effected health outcomes (Lee et al., 2009). So far, this study
has shown that those who have higher intake of fresh fruits, vegetables, olive oil, beans,
and nuts have improved moods and food choices, while desserts, soda, fast food, sweets,
and red meat were associated with a negative mood and additional negative food choices
(Ford, Jaceldo-Siegl, Lee, Youngbert, & Tonstad, 2013). Other preliminary results show
that those who experience poverty are more religious, but abused individuals are less
religious. Further, religious engagement may improve health outcomes for adults when
they experienced abuse early in life (Morton, Lee, Haviland, & Fraser, 2012).
Some of the limitations of the Adventist Health Studies are as follows:
1. Little dietary data on fruit and vegetable intake were collected in AMS, and
information was not gathered on meat substitutes that many Adventists use, such
as beans, nuts, and prepackaged vegetarian protein (Snowdon, 1988).
2. Information on social or church activities were not collected, despite these having
been shown to reduce mortality and could have created confounding on a
vegetarian diet and disease outcomes (Snowdon, 1988).
3. Four to seven percent of data items on the questionnaire were not answered,
including sensitive and nonsensitive items (Beeson et al., 1989).
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4. The questionnaire took on average between 1.25-3.5 hours to complete, and had a
low rate of males (34.9%) and Hispanics (0%). The questionnaire was not offered
in Spanish (Butler et al., 2008).
5. Since only Adventists are represented, the findings are less generalizable to other
non-Adventist vegetarians.
6. The baseline for the vegetarian and vegan diet were the Adventist meat-eaters,
who in general eat less meat than the general population (Le & Sabate, 2014).
This reporting may result in smaller observed effects.
The strengths of the Adventist Health Studies include the following:
1. Many studies have greater than 90% participant follow up; other researchers are
glad to get 50% on these kinds of studies.
2. Adventists have low alcohol and tobacco use, which reduces confounding and
increases statistical power.
3. There is church support at all levels: members are willing to participate in
research and administration encourages members to participate.
4. AHS-2 has an in-depth food questionnaire.
5. AHS-2 includes broad geographical locations.
6. AHS-2 includes a large number of Blacks.
7. AHS-2 includes a comprehensive calibration study measuring error and validity
(Butler et al., 2008).
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8. The focus of these studies represent vegetarian Adventists, and the study uses
consistent operational definitions of differing dietary patterns (Le & Sabate,
2014).
Complete Health Improvement Program (CHIP) History
In addition to the denominational-wide prospective Adventist Health Studies,
many members have also started independent health ministries, such as residential and
community health programs; CHIP is one such program. Hans Diehl founded the
Complete Health Improvement Program in 1986 after working with Nathan Pritikin, the
founder of the Pritikin Longevity Center, a residential, live-in lifestyle center (Morton et
al., 2014a). As participants progressed through this lifestyle program, Diehl found
significant improvements of their chronic diseases within only a few weeks. The Pritikin
Program guidelines consisted of a very low fat, low sodium, high fiber, plant-based diet,
except for one 3.5 ounce serving of fish or chicken once per week, 45-60 minutes of daily
exercise, and no alcohol, tobacco, or caffeine (Roberts, Nosratola, & Barnard, 2002). The
diet allowed for 10% fat, 25 mg of cholesterol, 10%-15% mainly plant protein, and 75%80% complex carbohydrates (Pritikin, 1984). Sixty-seven subjects (52 men and 15
women; mean age, 60±10 years) on the Pritikin three-week residential program showed a
31% reduction of metabolic syndrome by implementing the very low fat, high fiber, low
sodium diet (Sullivan & Klein, 2006). Eleven men (21%) showed a 41.3% reduction in
LDL, a 46.2% reduction in fasting insulin, a 13.6% drop in SBP, a 9.8% reduction in
DBP, a 41.3% reduction in TG, and a 14.8% drop in HDL (Roberts, Nosratola, &
Barnard, 2002).
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Seeing the limitations to this artificial but powerfully-principled residential health
setting, Diehl set out to create his own program teaching similar health principles, except
offering it in a 30-day community setting. His program cost less by negating the necessity
of having to leave work or travel distances, it provided community support, and allowed
participants to grow and adapt in their own home environment as they learned through
the program (Morton et al., 2014a). Diehl presented his first 4-week, 16-session CHIP
program in 1988 in Creston, British Columbia, Canada to an audience of 400. For the
next several years, he traveled in and out of the United States teaching CHIP.
The primary goal of the program was to reduce the symptoms associated with
heart disease and diabetes, such as high lipids, blood pressure, and blood sugars through a
whole-food, plant-based, vegan diet (Diehl, 1998). The secondary goal was to reduce
weight, reduce the need for pharmaceuticals, eliminate tobacco, improve stress, and
increase exercise (Diehl, 1998). The CHIP diet, called the Optimal Diet, and lifestyle
consists of 30 minutes of daily exercise (Morton et al., 2014b), 15% fat, 10%-15% plant
protein, 65%-70% complex carbohydrates, fewer than 50 mg cholesterol, fewer than 10
teaspoons sugar, low salt, at least 40 grams fiber, and 8-10 glasses of water (Englert,
Diehl, Greenlaw, Willich, & Aldana, 2007). Participants were encouraged to stop
smoking and attend monthly alumni meetings. CHIP was driven by the theory of planned
behavior (TBH; Ajzen, 1985), which included a strong educational component, targeting
attitudes, social norms, and perceived volitional control.
In 1997, sponsored by the Lifestyle Medicine Institute, the International Nutrition
Research Foundation, Borgess Health Alliance, and the Center for Science in the Public
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Interest, Diehl videoed the program for a live audience in Kalamazoo, Michigan and
presented the first research of that group in 1998 (Diehl, 1998). This program was
packaged into a curriculum for both professionally educated health professionals and
nonhealth trained volunteers who attended a 2-day CHIP training session (Rankin et al.,
2012). The Kalamazoo program graduated 288 self-selected, paying participants.
Being a health professional was not a criterion for volunteers since the directors
had only a facilitator’s role, not an educator’s role. Health education was presented by
Diehl via video, and the volunteers then directed group discussions, gave cooking
demonstrations, and provided grocery store tours. The volunteer channel has been largely
adopted by the Seventh-day Adventist church (Morton et al., 2014a). In 2000, Roger
Greenlaw initiated the professional CHIP channel with the Rockford cohort program,
enrolling 1,517 paying, self-selected participants between 2000 and 2002 (Englert et al.,
2007) with a goal of enrolling 5,000 participants over seven years, giving the program
every six months (Englert et al., 2004). CHIP continues to be an intensive educational
program given in 40 hours over four to five weeks, four evenings per week plus two
Sundays.
CHIP-Related Research
CHIP has now educated over 70,000 participants worldwide by professionals and
volunteers and has been written up in more than 25 publications (Morton et al., 2014a).
This present study made use of 22 peer-reviewed research studies on the CHIP program.
Seventeen CHIP studies examined healthcare professionals delivering the CHIP lifestyle
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intervention, seven examined volunteers, and one summarized the history of CHIP for
both volunteers and professionals, and all are discussed next.
First-recorded CHIP: Kalamazoo, Michigan. In 1997, Diehl delivered and
video recorded CHIP before 400 people in Kalamazoo, Michigan and published the first
CHIP results in the American Journal of Cardiology (Diehl, 1998). Two hundred and
eighty-eight graduated of the 304 enrollees (Diehl, 1988). Consistent with later CHIP
research, those with the greatest needs improved the most (Diehl, 1998; Englert et al.,
2004; Morton et al., 2014a; Rankin et al., 2012). Men who had cholesterol levels above
279 mg/dL reduced their cholesterol by 33%, 34% saw a reduction in LDLs with levels
greater than 189 mg/dL, 39% saw a reduction of TG if between 400 and 599 mg/dL, but a
lowering of HDL if their total-to-HDL cholesterol ratios were above 6.0 mg/dL (Diehl,
1998). Morbidly obese men (150% ideal body weight or higher) lost 13.7 pounds, the
most of any weight category after the four-week program. FPG also improved over the
program length. Thirty percent of those with diabetes cut their insulin by as much as
30%, which increased confounding, due to the reduction of diabetes and other
medications for hypertension and hyperlipidemia. The above results may actually be
more profound since most participants reduced or eliminated medications.
Though men improved more than women overall, women improved as well
(Diehl, 1998). Women lost on average 5.2 pounds, glucose dropped by 6.7%, TC dropped
by 21.6 %, and similar to men, dropped also in the good HDL cholesterol by 6.6 %,
which has subsequently been written up in Kent et al. (2013b).
Rockford CHIP: Professional-channel. The first publication from the
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professional Rockford CHIP cohort appeared in 2004 (Englert et al., 2004). Fifteen peerreviewed articles highlighted results from Rockford, all given by health professionals in
either a community (Englert, Diehl, & Greenlaw, 2012) or workplace setting (Aldana,
Greenlaw, Diehl, Englert, & Jackson, 2002). Another professionally delivered CHIP
intervention program out of Vanderbilt University (Shurney et al., 2012) published an
article tracking healthcare expenditures of employee participants for 26 weeks.
The Rockford CHIP (Englert et al., 2004; Englert et al., 2007) found similar
results in all biometrics as Kalamazoo, and additionally found reduced depression and
improved sleep and stress through nutrient improvement (Merrill, Taylor, & Aldana,
2008). However, serum C-reactive protein (CRP) did not significantly improve over
baseline despite improvements in weight, BMI, saturated fat, and body fat percentage
(Merrill et al., 2008). The researchers suggested that was possibly due to the small
sample size in an otherwise generally healthy population. In addition, as with the
Kalamazoo population, men in the Rockford population improved more over women,
though both improved, and those with the highest risk factors had the greatest
improvements, this included those with high blood sugar levels (Englert, Diehl,
Greenlaw, & Aldana, 2012). Of the 237 participants who had diabetes, 154 were on
diabetes medications, and 83 were unaware of their diabetes status. Forty-two percent of
participants on insulin, and 44% on oral antidiabetics were advised by their doctor to
reduce their dosage. Thirty-five percent reduced their glucose below 125 mg/dl and 10%
reduced it to below 100 mg/dl in 30 days.
CHIP volunteer-channel. In addition to the CHIP intervention being delivered

64
through a professional channel, it has also been largely adopted by the Seventh-day
Adventist church through a volunteer channel delivered by trained nonmedical people in
their local community (Morton et al., 2014a). Volunteers attended a 2-day training
workshop and learned about the video-presentations and their role as facilitators (Rankin
et al., 2012). To date, five peer-reviewed articles (Kent et al., 2013b; Kent et al., 2014;
Morton et al., 2014a; Morton et al., 2014b; Rankin et al., 2012) on the North American
volunteer programs have resulted from a dissertation by Rankin (2013), and since then,
groups from Australasia (New Zealand and Australia; Kent et al., 2013a; Morton et al.,
2013); and Appalachia, Ohio in the United States (Drozek et al., 2014) have also been
reported on. Morton et al. (2014b) gives a comprehensive picture of the CHIP history,
evaluation, outcomes, and comparisons of previous professional and volunteer programs
and Morton et al., (2014b) reported specifically on Canadian outcomes.
Of the seven volunteer-delivered research articles published in peer-reviewed
journals, one focused on the HDL implications in the metabolic syndrome and the
potential lack of its usefulness (Kent et al., 2013b); one focused on gender differences on
chronic risk factors (Kent et al., 2014); one examined aggregated outcomes of Canadian’s
pre- and postdisease risk factors—BMI, SBP, DBP, FPG, and blood lipid profile (Morton
et al., 2014b); one looked at the pre- and postdisease risk factors of the North American
CHIP cohort (Rankin et al., 2012); and one presented the CHIP history, evaluation, and
outcomes summarizing the risk factors in both the volunteer and professional delivered
programs (Morton et al., 2014a). The dissertation focused on reducing risk factors
associated with metabolic syndrome (Rankin, 2013).
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Similar to the North American disease risk factor results, rural Appalachia, Ohio
(Drozek et al., 2014) and Australasia (Morton et al., 2013) were also assessed for risk
factors immediately following the CHIP program. A subset of the Australasia cohort
(Kent et al., 2013a) was assessed for long-term effectiveness. Comparable to the
professionally-delivered, prerecorded CHIP intervention, the volunteer-delivered,
prerecorded CHIP intervention garnered similar results: those with the highest chronic
disease risk factors made the greatest improvements (Rankin et al., 2012), HDL dropped
despite improved outcomes in other risk factors (Kent et al., 2013a), and men improved
more than women, though both genders improved overall (Kent et al., 2014).
Both the professionally-delivered (PD) and volunteer-facilitated (VF) programs
assessed pre- and postbiometric changes in TC, HDL, LDL, TRI, BMI, SBP and DBP,
and FPG (Morton et al., 2014a). In aggregated data, the mean age for the VF (n=7085)
was 2.7 years older, at 56.8 years, than the professionally-delivered (PD; n=4678), both
had more females than males, BMI was reduced by 3.5% (PD) and 3.3% (VF), SBP drop
was equal at 5.0%, DBP dropped 5.2% (PD) and 5.1% (VF), TC dropped 11.3% (PD)
and 11.4% (VF), HDL dropped 9.1% (PD) and 13.4% (VF), LDL dropped 12.5% (PD)
and 8.6% (VF), TG dropped 7.3% (PD) and 8.1% (VF), and FPG dropped 5.5% (PD) and
6.1% (VF).
In comparison, considering the outcomes of the volunteer-delivered program, it
may present itself as a cost-effective adjunct to professional health care (Shurney et al.,
2012). Shurney et al. (2012) reported significant savings in medical costs in CHIP
participants with diabetes from the previous year’s quarter and after the CHIP program

66
the following year’s quarter. Medical costs were reduced by 45.5% and 40.3% in quarter
one and two compared to an increase in medical costs of 5.4% and 21.2% in the same
two quarters for non-CHIP participants with diabetes. Prescription costs also declined by
14.7% and 13.8% in quarter one and two for CHIP participants, but rose by 11.5% and
7.6% for non-CHIP participants. The average number of office visits was significantly
reduced, as was the number of prescriptions filled. Other comprehensive lifestyle
modification programs have seen similar results such as the Diabetes Prevention Program
(DPP), which has shown prevention or delay in diabetes incidences for 10 years for
lifestyle (34% reduction) versus metformin (18% reduction; Knowler et al., 2009), but
without the pharmaceutical side effects (Hung et al., 2015; Kalantar-Zadeh & Rhee,
2015).
Several factors may explain the significant biometric risk reduction as observed in
the CHIP intervention. Participants were self-selected and may have been more motivated
and ready for change, as shown by a low attrition rate (3%), the necessity to pay for the
program (Morton et al., 2014b), and a short 4-week intervention (Morton et al., 2014a).
Limitations in the CHIP intervention included a lack of control group, and compliancy
was not evaluated. A confounding factor was that many participants either discontinued
or reduced their medication use, potentially diminishing the observed effectiveness in
biometrics (Rankin et al., 2012). Despite the limitations, CHIP’s strength is the sample
size, and the strong and focused educational element, which concentrates on
comprehensive lifestyle choices of improving diet, exercise, and sleep, stress reduction,
emotional health and self-worth, overcoming obstacles, and maintenance (Kent et al.,
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2014). CHIP addresses the root causes of diabetes, which is diet and lifestyle.
Although most volunteer-facilitated CHIP programs are presented by Adventists,
and a body of evidence exists comparing mean changes in the pre- and postprogram
disease risk factors and between genders, a literature gap exists when it comes to
understanding how having a specific faith belief may affect biometric outcomes within
the CHIP program for those with type 2 diabetes. It is also unknown if Adventists enter
the CHIP program with a different rate of diabetes compared to non-Adventists.
CHIP Video-Presentation
The volunteer- and professionally-delivered CHIP program consisted of sixteen 2hour group sessions, which included a 1-hour recorded health lecture by the founder,
Diehl, live demonstration cooking classes, a grocery store tour, group discussions, and
exercise classes (Englert et al., 2004; Rankin et al., 2012). Video content instructions
included the following:
•

plant-based nutrition

•

exercise

•

behavioral change

•

self-worth

•

accomplishments and limitations of modern medicine

•

smoking

•

cholesterol

•

dietary fiber

•

lifestyle and health
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•

CVD

•

diabetes

•

atherosclerosis

•

hypertension

•

obesity

•

dyslipidemia (Englert et al., 2004; Rankin et al., 2012)

Video-facilitated education has been used successfully in a variety of health
education programs. Maltinsky, Hall, Grant, Simpson, and MacRury (2013) evaluated a
work-based pilot video conferencing program targeting diabetes education for rural
healthcare professionals with limited training options. Video conferencing promoted
equal learning as in-person, but had less spontaneous interaction with the instructor. A
different qualitative, motivational, video-based program (Essien et al., 2011) assessed the
cost-effectiveness, stability, and feasibility in HIV prevention for women in Southwestern
Nigeria (n=346) where resources were limited. The results indicated that both the
interventional motivational video and the control didactic video equally increased HIV
knowledge, but the motivational video significantly improved condom use and reduced
the number of sexual partners and alcohol use before sex at the six-month follow up over
the didactic video. The limitation in this study is that all behavioral outcomes were selfreported, and subjects were from a convenience sample. However, there was random
assignment, and retention rate was high.
In another study, a tuberculosis (TB) video-education program shown to
immigrants and refugees in an English as a Second Language (ESL) classroom entering
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the United States (n=159) increased TB knowledge, with participants increasing test
scores from 56% to 82% correct. Ninety-four percent of those using ESL stated the video
instruction format was appropriate for learning, and self-efficacy increased from 77% to
90% (Wieland et al., 2013). Overall, knowledge increased significantly in all learning
sections by viewing video-recorded educational sessions. These studies and others
highlight the effectiveness of using a prerecorded educational video as a learning medium
(Canter, Rao, Patrick, Alpan, & Altman, 2015).
Volunteer-Delivered Lifestyle Programs
Volunteer-faciliated, community-based, lifestyle programs have the potential to
impact larger numbers of people while reducing costs significantly (Baron et al., 2008;
Knowler et al., 2009; Siabani, Driscoll, Davidson, & Leeder, 2014; Shurney et al., 2012).
The purpose of this dissertation was to analyze the volunteer-facilitated aspect of the
CHIP intervention, though medical professionals also present the intervention program
and have been studied separately. The CHIP intervention has mainly been adopted by
volunteers from the Seventh-day Adventist church wishing to affect positive change in
their community (Morton et al., 2014a). Extant literature reveals the most common
volunteer setting is related to a health-orientation setting, with the volunteer possessing a
protestant or Catholic religious affiliation, and who engages in prayer with altruistic
values (Moore, Warta, & Erichsen, 2014).
In other research, health indicators for chronic heart failure (Siabani et al., 2014),
CVD risk factors (Rankin et al., 2012), and an at-home exercise program (Castro, Pruitt,
Buman, & King, 2011; Etkin, Prohaska, Harris, Latham, & Jette, 2006) also improved
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following educational programs presented by trained volunteers. More encouraging,
some research shows that trained volunteers may be more effective than paid
professionals (Castro et al., 2011), and equally as effective (Morton et al., 2014b).
Whether the trained volunteer is a peer or an undergraduate college student and younger,
participants significantly improve their health outcomes under their guidance (Dorgo,
King, & Brickey, 2009). Research shows that both participants and volunteers benefit in
perception, enjoyment, motivation, role modeling, and retention whether receiving or
presenting the program (Dorgo et al., 2009).
Summary and Conclusion
Diabetes is having a substantial impact on society in health and life expectancy
and in health care costs for individuals, employers, and state and federal budgets. A
plethora of dated and contemporary evidence exists in the literature showing the
effectiveness of a comprehensive lifestyle, plant-based, vegan program in the reduction
of chronic diseases such as diabetes and CVD; the cure and reversal is in the cause.
Adventists have been successfully sharing a progressive and unique health message with
the world in a multitude of settings since the 1840s, which reverses and reduces the risk
of disease. Studies also show that lifestyle approaches are more cost-effective than a
pharmaceutical, Western type of approach while reducing medication usage. Research
reveals that Adventists and non-Adventists who follow this counsel and adhere to a plantbased diet have lower incidences of diabetes and CVD. Adventist programs such as CHIP
focus on diet, exercise, and stress reduction and have the potential to impact large
numbers of people while reducing costs significantly due to targeting the root cause of
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disease. Despite a lack of control group and selection bias, with its large sample size, the
CHIP modification intervention has shown to be an effective 30-day, community-based,
video-presented, plant-based, lifestyle program delivered by both volunteers and
professionals. The CHIP research has been consistent showing that participants with the
greatest needs improved the most, and men improved more than women did though all
improved. However, despite the volunteer program being presented and adopted mainly
by the Adventist church, there was a research gap when assessing program effectiveness
between Adventists and non-Adventists with diabetes.
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Chapter 3: Research Method
Introduction
The purposes of this study were to determine the relationship between religiosity
and preprogram diabetic rate, and to compare if having a particular religious belief
(Adventist or non-Adventist) significantly affected biometric outcomes for those with
type 2 diabetes pre- and post-CHIP. This quantitative, correlational, secondary data,
research design study examined the rate difference between religiosity and self-identified
preprogram diabetic state, and assessed how religiosity affected postbiometrics. The
Walden University Institutional Review Board (IRB) approved this research with
approval number 11-09-15-0065108.
The following research questions guided this study:
Research Question 1 (RQ1): After controlling the effects of age, gender, marital
status, BMI, and parental death from diabetes before age 60, is there a statistically
significant difference in self-identified type 2 diabetes prevalence rates between
Adventist and non-Adventist CHIP participants preprogram between January 2006 and
September 2012?
H01: The self-identified diabetes prevalence rate between Adventist and nonAdventist in pre-CHIP participants is not significantly different.
H11: The self-identified diabetes prevalence rate between Adventist and nonAdventist in pre-CHIP participants is significantly different.
The quantitative test used to answer RQ1 was logistic regression.
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Research Question 2 (RQ2): After controlling for the effects of age, gender,
marital status, and parental death from diabetes before age 60, is there a statistically
significant difference in the change in biometric outcomes (TC, HDL, LDL, TG, FPG,
SBP, DBP, and BMI) between Adventists and non-Adventists with self-identified
diabetes pre- and post-CHIP between January 2006 and September 2012?
H02: There is no statistically significant difference in biometric outcomes
between Adventists and non-Adventists with self-identified type 2 diabetes pre- and postCHIP.
H12: There is a statistically significant difference in biometric outcomes between
Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-CHIP.
The quantitative test used to answer RQ2 was a MANOVA.
Research Design and Rationale
This study utilized a quantitative methodology with a correlational design using a
secondary data set from CHIP. This quantitative approach was selected in order to
understand statistically how lifestyle factors relate to disease outcomes and having a
specific faith belief. Correlational research was conducted because this design looks at
relationships among variables (Leedy and Omrod, 2010). There were no time or resource
constraints in this study; the overall objective was to determine the relationships between
the variables of religiosity, preprogram diabetic state, and biometric outcomes.
In RQ1, the independent variables were religiosity and pre- and post-CHIP
measurement testing periods. The dependent variable was self-identified diabetes, having
been told by a doctor they have diabetes, and the covariates were age, gender, marital
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status, BMI, and parental death from diabetes before age 60. In answering RQ1, an
experimental design using logistic regression was employed to quantify the difference in
diabetes rate between Adventists and non-Adventists.
The independent variables for RQ2 were religiosity and testing period. The
dependent variables were the biomarker outcomes attained through blood sample testing
for TC, HDL, LDL, TG, and FPG and the clinical parameters of SBP, DBP, height and
weight measurements for BMI, and the covariates were age, gender, marital status, and
parental death of diabetes before age 60. In answering RQ2, MANOVA, a correlational
research design was used to quantify the biometric changes from pre- to post-CHIP in
Adventists and non-Adventists with type 2 diabetes.
Methodology
Population
The total population of 7,172 included community members from 241 programs
located at 163 venues throughout Canada and United States between January 2006 and
September 2012. The population consisted of those who self-identified themselves as
Adventist or non-Adventist, self-identified themselves on the health-screening
questionnaire as having been told by a doctor they had diabetes, and graduated from the
CHIP program. The CHIP participants underwent a total of 32 hours of instruction over a
30-day period that included the following:
● a one-hour video-instruction health lecture by Hans Diehl
● cooking classes
● grocery store tours
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● group discussions
● exercise instruction (Rankin et al., 2012)
● instruction on intelligent self-care through more self-awareness of what their
body needed and how it felt.
The one-hour video-instruction included education on the following:
● a plant-based diet
● exercise
● behavioral change
● self-worth
● modern medicine’s strengths and weaknesses
● smoking
● cholesterol
● fiber
● lifestyle and health
● the epidemiology and risk factors of CVD, diabetes, atherosclerosis,
hypertension, obesity, and dyslipidemia (Rankin et al., 2012).
Participants were also encouraged to move towards a whole-food, plant-based,
vegan diet emphasizing fresh fruits and vegetables, whole grains, legumes, and nuts
without emphasis on caloric restriction. Specific dietary and lifestyle recommendations
included the following:
● <15% of calories from fat
● <10 teaspoons of added sugar
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● <5,000 mg salt (2,000 mg sodium)
● <50 mg cholesterol
● consuming 2-2.5 liters or eight 10-ounce glasses of water daily
● 30 minutes of daily aerobic exercise
● stress reduction strategies
● encouragement to join the CHIP monthly alumni support group (Rankin et al.,
2012).
Participants were also encouraged to maintain contact with their physician
throughout the program, since experience has shown many participants need to have their
medications reduced due to these lifestyle changes. Prior to CHIP, all filled out a
preprogram baseline health questionnaire, and again post-CHIP. Included were questions
about demographics, medication use, medical and family history, use of tobacco, alcohol,
and caffeine, religiosity, and behaviors of activity, rest, and diet. Trained phlebotomists
also drew blood for TC, HDL, LDL, TG, and FPG. Each participant was weighed and
measured for height to calculate BMI and had their blood pressure taken.
There were no restrictions on participant demographics of age, gender, marital
status, BMI, or parental death of diabetes prior to age 60, and were controlled for. To be
included, participants had to have graduated from a CHIP program, defined as having
attended at least 13 of 16 sessions, completed a self-reported medical and lifestyle
prequestionnaire, and completed both the pre- and postprogram assessment.
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Sampling and Sampling Procedure
The required sample size for this study was calculated to determine the number of
samples necessary for a statistically significant result. The sample size was calculated
considering three factors: (a) effect size, (b) level of significance, and (c) power of the
study. Cohen’s (1988) effect size accounts for the strength of the relationship between
variables. The level of significance or alpha level was used to assess the null hypothesis,
providing it was true, for the probability of its rejection. The power of the study was
determined by the probability of being able to reject a false null hypothesis. A Cohen
medium effect size of 0.25, a power of 0.80, and a level of significance of 0.05 were used
in this study. A power of 0.80 is in alignment with Gravetter and Wallnau’s (2013)
statement, which is normal for quantitative research. Use of the medium effect size was
intended to prevent excessiveness in terms of either leniency or strictness,
simultaneously. A significance level of 0.05 was used because this is typical for
quantitative studies.
A G*Power sample calculator was used to compute the required sample size for
this study, as suggested by Faul, Erdfelder, Lang, and Buchner (2009). A two-tailed or
nondirectional hypothesis test was conducted, employing the statistical test of repeated
measures MANOVA with two groups (Adventists with diabetes and non-Adventists with
diabetes) and two numbers of measurements (pre- and postprogram). A medium effect
size in the sample size computation involved in the repeated measures MANOVA, and
the value of the medium effect size for an ANCOVA test is 0.25. A medium effect size
was chosen so that the G*power computation can neither have a very small or large
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sample size. The important factors under consideration were to be able to achieve an 80%
power in the statistical analysis, which meets the minimum size for a quantitative
analysis, and to have a level of significance of 0.05.
The minimum sample size for this study computed by the G*Power sample size
calculator was 66 (see Appendix A). A minimum of 66 individuals had to be included so
that the power of the statistical analysis reached 80%, which would allow the null
hypothesis to be rejected. To account for the minimum 66-sample requirement, the
participants were divided among the two sample groups of Adventists with diabetes
(n=210) and non-Adventists with diabetes (n=836), for a total of 1,046 data sets.
Data were obtained from the CHIP database, a secondary source. A purposeful
sampling strategy was chosen because study participants had to match inclusion criteria
in order to be eligible for participation in the study. The inclusion criteria were as
follows: self-identified as Adventist or non-Adventist; self-identified as having diabetes;
having graduated from CHIP, and filled out the proper questionnaires. All ages in the
original samples were included.
Procedures for Recruitments, Participation, and Data Collection: Using Archival
Data
The data required for RQ1 included the dependent variable of diabetes state; the
independent variables of self-reported religiosity affiliation and testing period; and the
covariates of age, gender, marital status, BMI, and parental death from diabetes before
age 60. The data required for RQ2 included the dependent variables of TC, HDL, LDL,
TG, FPG, SBP, DBP, and height and weight calculated for BMI; religious affiliation and
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testing period as the independent variables; and the covariates of age, gender, marital
status, and parental death of diabetes prior to age 60. BMI was a covariate for RQ1 and
an outcome variable for RQ2. The variable information was obtained through secondary
data collection from the CHIP database between January 2006 and September 2012.
Secondary data were obtained from the CHIP database and its analysis used as an
investigative tool for answering new questions (Andrews, Higgins, Andrews, & Lalor,
2012).
To achieve access, a written request for permission to utilize CHIP information
was submitted to the Lifestyle Medicine Institute with a description of how it was to be
used. This email consisted of the permission letter, an explanation of the purpose of the
study, and how the data were to be used in the study. In return, the CHIP organization
will receive an overall summary report at the study’s conclusion.
The CHIP database resides in Wahroonga, Australia. In the course of my contacts
with CHIP researchers, they had given permission and encouragement to analyze the
CHIP data for this study. See data use agreement in appendix C. The data from the CHIP
database represented 7,172 unidentifiable, self-selected subjects from 241 volunteerdelivered CHIP programs conducted at 163 locations throughout Canada and the United
States between January 2006 and September 2012. The CHIP database consisted of age,
gender, marital status, TC, HDL, LDL, TG, SBP, DBP, FPG, BMI, and self-identified
diseases and religious affiliation.
The deidentified data set was provided in an Excel spreadsheet format that needed
to be uploaded to statistical assessment software, SPSS v23.0. In order to maintain
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anonymity codes were assigned in place of participants’ names. Data preparation was
conducted in an Excel sheet to prepare for data analysis. The columns displayed the study
variables as an enumerated list, while the rows listed the response data of the different
samples.
Instrumentation and Operationalization of Constructs
The data gathered through the CHIP database were representative of the total
sample of Adventists and non-Adventists who had diabetes since it included all
participants who participated under the volunteer-branch of CHIP between January 2006
and September 2012. The data gathered from the data source were analyzed using SPSS
v23.0 software in preparation for the data analysis. There were no issues with the validity
and reliability of the data, as they were derived from both secondary and preexisting
sources. No testing or survey assessments were used with the targeted samples. It was
expected that the data of the samples in the CHIP database were complete. The coding
and operationalization of the study variables are presented in Table 1 below.
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Table 1
Operationalization and Coding of Study Variables
Variable Name

Variable Type

Operationalization

Coding/Values

Self-identified
preprogram
diabetic state
High-density
lipoproteins
Low-density
lipoproteins
Triglycerides

Dependent
variable

Categorical

1 = Previous history
2 = No previous history

Continuous

Actual number of HDL

Continuous

Actual number of LDL

Continuous

Actual number of TG

Continuous

Actual number of TC

Fasting plasma
glucose
Systolic blood
pressure

Dependent
variable
Dependent
variable
Dependent
variable
Dependent
variable
Dependent
variable
Dependent
variable

Continuous

Actual number of FPG

Continuous

Diastolic blood
pressure

Dependent
variable

Continuous

Body mass index

Dependent
variable

Continuous

Religiosity selfidentified
affiliation as a
Seventh-day
Adventist
Testing period

Independent
variable

Categorical

Actual number of systolic blood
pressure or the top number of
the blood pressure chart
Actual number of diastolic blood
pressure or the bottom number of
the blood pressure chart
Actual number of body mass index
computed by dividing the weight
in kilograms (kg) with the height
in centimeters (cm) squared at
baseline
1/True = Seventh-day Adventist
2/False = non-Adventist

Independent
variable

Categorical

0 = Pretest
1 = Posttest

Age

Covariates

Continuous

Gender

Covariates

Categorical

Actual number of age at baseline
date of birth
1 = Male

Total cholesterol

2 = Female
Marital status

Covariate

Categorical

Parental death
from type 2
diabetes before
age 60

Covariate

Categorical

1 = Single, divorced, or widowed
2 = Married
1 = With family history
2 = No family history
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Data Analysis Plan
Data were analyzed using SPSS version 23.0. Normality testing was conducted on
the data of the study variables of the population to ensure that the assumptions required
for a parametric statistical test were fulfilled. The analysis was conducted by examining
the skewness and kurtosis statistics, as well as the normality plots in the histograms.
Normal distribution of data were a required assumption of parametric statistical analysis
such as the MANOVA analysis. In addition, a line graph was created from the data of
each study variable to account for the possible presence of anomalous figures or
noticeable outliers within the data prior to conducting the statistical analysis. These
outliers were removed from the data set.
Descriptive and inferential statistics were used to analyze the data gathered and
presented in Chapter 4. Descriptive statistics describe the demographics and other
information of the samples and study variables obtained from the CHIP database.
Frequencies and percentages describe categorical data, such as the dependent variable of
biometric outcomes, the independent variables of religiosity and testing period, and the
covariates of gender, marital status, and parental death from diabetes prior to age 60.
Central tendency measures of mean and standard deviation summarizes the continuous
variability of the dependent variables, which included the biometric measurements of TC,
HDL, LDL, TG, and FPG; height and weight measured for BMI, SBP, and DBP; and the
covariate of age. Percentages of those who met the criteria of each biometric variable preand post-CHIP were added to provide information on the percentage of those who met or
fell within the normal range for these biometrics pre- and postprogram.
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The research questions, hypotheses, and discussion on specific analysis follows.
Research Question 1 (RQ1): After controlling the effects of age, gender, marital
status, BMI, and parental death from diabetes before age 60, is there a statistically
significant difference in self-identified type 2 diabetes prevalence rates between
Adventist and non-Adventist CHIP participants preprogram between January 2006 and
September 2012?
H01: The self-identified diabetes prevalence rate between Adventist and nonAdventist in pre-CHIP participants is not significantly different.
H11: The self-identified diabetes prevalence rate between Adventist and nonAdventist in pre-CHIP participants is significantly different.
The dependent variable tracked in answering RQ1 was self-identified diabetes.
The independent variables were religiosity and testing period. The five covariates were:
age, gender, marital status, BMI, and parental death from diabetes before age 60. The
quantitative test used to answer this question was logistic regression.
To answer RQ1, I conducted a logistic regression analysis to investigate whether
there was a significant difference in the self-identified preprogram diabetes rate between
Adventists and non-Adventists, while controlling the effects of the covariates of age,
gender, marital status, BMI, and parental death from diabetes before age 60. RQ1 dealt
solely with the preprogram data and involved comparing Adventists and non-Adventists.
Logistic regression determined whether religious affiliation predicted the dichotomous
dependent variable of whether a subject had preprogram diabetes. Using logistic
regression was justifiable because the dependent variable was a categorical dichotomous
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variable, the independent variables were categorical dichotomous, while the covariates
are continuous variables either measured as intervals or ratios. The value of a continuous
variable is not limited to a certain range, but rather continuous within a certain interval. A
level of significance of 0.05 was used in the hypothesis testing.
Research Question 2 (RQ2): After controlling for the effects of age, gender,
marital status, and parental death from diabetes before age 60, is there a statistically
significant difference in the change in biometric outcomes (TC, HDL, LDL, TG, FPG,
SBP, DBP, and BMI) between Adventists and non-Adventists with self-identified
diabetes pre- and post-CHIP between January 2006 and September 2012?
H02: There is no statistically significant difference in biometric outcomes
between Adventists and non-Adventists with self-identified type 2 diabetes pre- and postCHIP.
H12: There is a statistically significant difference in biometric outcomes between
Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-CHIP.
The dependent variables tracked in answering RQ2 were TC, HDL, LDL, TG,
FPG, SBP, DBP, and BMI. The independent variables were religiosity and testing period.
The covariates were age, gender, marital status, and parental death from diabetes before
age 60. The quantitative test used to answer RQ2 was MANOVA.
To answer RQ2, I conducted a repeated measures MANOVA. This test was
performed to determine whether the dependent variables of the biometric outcomes were
significantly different across the independent variables of religiosity with diabetes and
the repeated measure of the testing period while controlling the effects of the covariates.
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A repeated measures MANOVA was used because the independent variables were
categorically measured and had more than two identified groups. This approach was also
used because there were multiple dependent variables determining the effects of the
covariates (Babbie, 2012). The repeated measures MANOVA determined whether there
were differences between independent groups on more than one dependent variable while
also examining the difference between the preintervention and postintervention
measurements of the participants.
The independent variables in the repeated measures MANOVA were religiosity
with diabetes while the repeated measure was the testing period. The dependent variables
included the biometric measurements of TC, HDL, LDL, TG, FPG, SBP, DBP, and BMI,
as well as the covariates of age, gender, marital status, and parental death from diabetes
prior to age 60. The repeated measures MANOVA determined whether the religiosity
with diabetes and testing period significantly accounted for variations in the biometric
outcomes, while controlling for the influences of age, gender, marital status, and parental
death from diabetes prior to age 60. The analysis of multiple independent variables,
dependent variables, and covariates was included in one repeated measures MANOVA
analysis in order to compare the effects of various independent variables on the
dependent variables. In addition, the repeated measure as represented by the variable
testing period on the dependent variables was also investigated to determine whether the
effects of religiosity with diabetes on dependent variables were significantly different in
the pretest and posttest period.
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The effect examination for the repeated measure of the testing period determined
whether the CHIP intervention had an effect on the biometrics. A significance level of
0.05 was used in the analyses. There was a significant difference or relationship if the pvalue was less than or equal to the level of the significance value. In instances wherein
the repeated measures MANOVA determined significant relationships between
independent and dependent variables, a post hoc Tukey’s test of multiple comparisons
was conducted to further identify the relationships.
Threats to Validity
This study had very few threats to validity; the data obtained from this known
database has been extensively used in previous research involving chronic disease risk
factors (Kent et al., 2013b; Kent et al. 2014; Morton et al., 2014a; Morton et al., 2014b;
Rankin et al., 2012). One of the threats to the external validity of the study was
nonresponse bias because it could affect generalizing to other populations, wherein the
data set of samples is not complete because some of the information from the study
variables was missing. The threat caused a slight decrease in the sample size. As a result,
this study involved a reasonable number of samples computed from the power analysis. It
was ensured that all of the data for each of the study variables collected from the CHIP
database were complete. The number of samples collected was greater than the minimum
of 66 data sets required to set a certain allowance.
Ethical Procedures
This study was reviewed and approved by members of the Walden’s Institutional
Review Board (IRB) with approval number 11-09-15-0065108. Because secondary data
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were used in this study and the data were preexisting and previously gathered, it was not
necessary to use informed consent forms, nor were there ethical concerns. However,
permission to use and access the CHIP database was obtained prior to its use in the study.
It was important to ensure the confidentiality and anonymity of the individual data
considered in the study and no identifiable information was obtained or used in this
study. All of the data sets from the samples obtained from the database was coded to
ensure that each individual’s responses remained unidentifiable; all data came to me
deidentified.
All data gathered in this study will be kept in a username and password-protected
computer, which will only be accessed by me. Data obtained from the database will be
stored for a minimum of five years per Walden’s procedure. Any data stored on a hard
drive will be electronically deleted after five years. I had no conflicts of interest related to
this study, and no incentives were used in this study.
Summary
Chapter 3 included a discussion of the research design, population, sampling and
sampling procedures, instrumentation and operationalization of constructs, data collection
procedures and recruitment of participants, data analysis plan, threats to validity, and
ethical procedures. This study involved a quantitative research design with the objective
of determining relationships between religiosity and preprogram diabetic state and
religiosity with diabetic disease state and biometric outcomes. Secondary data were used
from the CHIP database to obtain information on the pre- and post-CHIP measurements
of the independent variables of religiosity with diabetes, and testing period, the dependent
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variables, and the covariates. Data analysis in SPSS version 23.0 included descriptive
statistics, logistic regression, and MANOVA, which addressed the research questions of
the study.
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Chapter 4: Results
Introduction
The purpose of this quantitative correlational study was to determine the
relationship between religious affiliation and preprogram diabetic state, and comparing
religiosity and biometric outcomes in those with type 2 diabetes pre- and post-CHIP. This
study utilized a secondary data set from CHIP to investigate if there was a significant
difference in the self-identified preprogram diabetic state between Adventists and nonAdventists, and examined how a particular religious affiliation (Adventist or nonAdventist) in those with type 2 diabetes affected eight biometric outcomes pre- and postCHIP intervention. The study data were analyzed using logistic regression analysis and a
repeated measures MANOVA to address the two primary research questions. The
following research questions and hypotheses guided the analysis for this study:
Research Question 1 (RQ1): After controlling the effects of age, gender, marital
status, BMI, and parental death from diabetes before age 60, is there a statistically
significant difference in self-identified type 2 diabetes prevalence rates between
Adventist and non-Adventist CHIP participants preprogram between January 2006 and
September 2012?
H01: The self-identified diabetes prevalence rate between Adventist and nonAdventist in pre-CHIP participants is not significantly different.
H11: The self-identified diabetes prevalence rate between Adventist and nonAdventist in pre-CHIP participants is significantly different.
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Research Question 2 (RQ2): After controlling for the effects of age, gender,
marital status, and parental death from diabetes before age 60, is there a statistically
significant difference in the change in biometric outcomes (TC, HDL, LDL, TG, FPG,
SBP, DBP, and BMI) between Adventists and non-Adventists with self-identified
diabetes pre- and post-CHIP between January 2006 and September 2012?
H02: There is no statistically significant difference in biometric outcomes
between Adventists and non-Adventists with self-identified type 2 diabetes pre- and postCHIP.
H12: There is a statistically significant difference in biometric outcomes between
Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-CHIP.
In overview, this chapter addresses the research questions and the statistical
analysis results by section. First, the demographic information is provided for the CHIP
samples; second, the descriptive statistics of study variables are provided; third, the
statistical tests are discussed for RQ1 and RQ2; fourth, the logistic regression analysis
and repeated measures MANOVA are presented for each biometric pre- and
postprogram.
Data Collection
The population of respondents consisted of 7,172 self-selected Adventists and
non-Adventists that attended the CHIP program between January 2006 and September
2012. There were no discrepancies in data collected to the plan presented in chapter 3.
The frequency and percentage summaries of the participants’ demographic variables of
self-identified diabetes, religiosity, gender, marital status, and parental death from
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diabetes prior to age 60 are summarized in Table 2. Of the total 7,172 CHIP participants,
14.6% (1,036) self-identified themselves as having been told by a physician they had
diabetes; 21.2% (1,523) self-identified Adventist affiliation; 78.8% (5,649) self-identified
as non-Adventist. There were more married participants (64.3%; 4,614) than single,
divorced, or widowed (22.5%; 1,612), and 66.6% (4,774) were women. Two hundred and
thirty-three (3.2%) participants reported a history of parental death from type 2 diabetes
before age 60. Descriptive statistics of mean and standard deviation were used to
summarize the data regarding age (Table 3). The average age of the population was 57.38
years (SD = 13.01), ranging from 9 to 103, with 86 participants under 18 years old. Two
hundred and ten (210) Adventists self-identified as having diabetes preprogram,
compared to 836 non-Adventists (see Table 4). No participants under 18 years old were
reported as having diabetes.
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Table 2
Frequency and Percentage Summaries of Demographic Information (N = 7,172)
n

Category
Self-identified preprogram diabetic state
No previous history with diabetes
Previous history with diabetes

%

6,126
1,036

85.4
14.5

10

0.1

Non-Adventist

5,649

78.8

Adventist

1,523

21.2

Male

2,394

33.4

Female

4,774

66.6

4

<0.1

Single, divorced, widowed

1,612

22.5

Married

4,614

64.3

Missing

946

13.2

233

3.2

No family history

4,399

61.3

Missing

2,540

35.4

Missing
Religiosity self-identified affiliation as a Seventh-day Adventist

Gender

Missing
Marital Status

Parental death from type 2 diabetes before age 60
With family history

Table 3
Descriptive Statistics Summaries of Age (N = 7,172)
N
7164

Minimum
9

Maximum
103

M
57.38

SD
13.01
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Table 4
Cross Tabulation of Religiosity and Self-Identified Preprogram Diabetic State (N =
6,126)
Self-identified preprogram diabetic
state

Religious affiliation

No

Religiosity self-identified
affiliation as Seventh-day
Adventist

Total

Yes

n

%

n

%

n

%

Non-Adventist

4,783

78.1

836

79.9

5,619

78.3

Adventist

1,343

21.9

210

20.1

1,553

21.7

6,126

100.0

1,046

100.0

7,172

100.0

Total

Results
Descriptive Statistics of Study Variables
Table 5 summarizes the descriptive statistics of the study variables. Descriptive
statistics of means and standard deviation were used to summarize the data of the
continuous-measured study variables, which were the dependent variables of the
biometric outcomes (TC, HDL, LDL, TG, FPG, SBP, DBP, and BMI). The statistics
included the summaries of the responses in the self-reported medical and lifestyle
prequestionnaire and the pre- and postassessment questionnaire.
The comparison of the pre- and postprogram assessment showed that all
biometrics of the population mean change were lower after completing CHIP. The largest
improvements were seen in those who resided in the highest risk category except LDL.
From pre- to postclass, the largest mean change reductions were seen in the TG outcomes
from 639.61 to 629.11 (-10.50 mg/dl), FPG from 165.86 to 156.66 (-6.12 mg/dl), TC
from 309.46 to 305.46 (-4.01 mg/dl), DBP from 110.66 to 107.53 (-3.13 mmHg), and
SBP from 173.80 to 172.45 (-1.35 mmHg). The majority of participants (36.82 preclass
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mean and 36.42 postclass mean) were in the ≥30 BMI category both preprogram
(n=3534/49.3%) and postprogram (n=2860/39.9%). The largest mean change in LDL
were those within the normal range and dropped their mean change by -3.39 mg/dl (79.37
to 75.98). From pre- to postclass, 14.8% more participants met the normal criteria for TC,
an additional 12.3% met the normal criteria for LDL, 5.0% more met the criteria for a
normal FPG, 9.6% more met the normal criteria for a normal SBP, 11.4% more met the
normal criteria for DBP, an additional 2.9% met the normal BMI criteria, 7.7% less
participants met the criteria for a normal HDL, and 0.4 less participants met the normal
criteria for a normal TG.
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Table 5
Descriptive Statistics Scores of Pre- and Postprogram Biometric Outcomes Categorized
by Disease Risk Factor (n=7,172)
Risk Factor

Preprogram

Postprogram

Preprogram

Postprogram

n (%)

n (%)

(Mean + SD)

(Mean + SD)

Mean change (95%
confidence interval) (%)

Total cholesterol, mg/dl
<160

1550 (21.6)

2611 (36.4)

139.42 + 16.00

135.96 + 17.17

-3.46 (5.57, 7.68) (-2.48)

160-199

2689 (37.5)

2585 (38.9)

180.06 + 11.25

178.33 + 11.31

-1.72 (15.62, 17.29) (-0.96)

200-239

1976 (27.6)

1148 (17.3)

217.20 + 11.25

215.37 + 10.91

-1.83 (26.07, 28.29) (-0.84)

240-280

721(10.1)

256 (3.39)

255.07 + 10.91

254.47 + 10.83

-0.60 (37.50, 42.05) (-0.24)

>280

182 (2.5)

42 (0.6)

309.46 + 34.81

305.46 + 21.40

-4.01 (53.23, 68.14) (-1.30)

High-density lipoproteins, mg/dl
<40

3397 (47.4)

4073 (56.8)

37.99 + 6.88

37.12 + 6.99

-0.87 (1.52, 1.91) (-2.28)

40-60

2252 (31.4)

1699 (23.7)

50.76 + 5.52

50.72 + 5.60

-0.04 (4.08, 4.66) (-0.07)

>60

1465 (20.4)

867 (12.1)

71.21 + 11.82

69.48 + 10.41

-1.73 (8.86, 9.94) (-2.43)

Low-density lipoproteins, mg/dl
<100

2392 (33.4)

3275 (45.7)

79.37 + 15.48

75.98 + 16.46

-3.39 (4.01, 5.52) (-4.28)

100-129

2299 (32.1)

2118 (29.5)

114.17 + 8.60

113.24 + 8.40

-0.93 (12.21, 13.84) (-0.82)

130-159

1520 (21.2)

895 (12.5)

142.48 + 8.50

141.87 + 8.51

-0.61 (21.30, 23.55) (-0.43)

160-190

576 (8.0)

222 (3.1)

171.14 + 8.1

171.02 + 8.06

-0.12 (29.21, 33.32) (-0.07)

>190

213 (3.0)

59 (0.8)

209.61 + 21.04

209.10 + 23.43

-0.52 (41.84, 50.80) (-0.25)

Triglycerides, mg/dl
<150

4629 (64.5)

4597 (64.1)

94.67 + 29.95

94.54 + 29.37

-0.13 (-5.84, -3.80) (-0.14)

150-199

1184 (16.5)

1075 (15.0)

171.56 + 13.81

171.47 + 14.22

-0.09 (11.08, 17.10) (-0.05)

200-500

1233 (17.2)

950 (13.2)

269.99 + 62.76

265.23 + 60.51

-4.76 (46.67, 55.55) (-1.76)

>500

60 (0.8)

15 (0.2)

639.61 + 118.10

629.11 + 85.70

-10.50 (237.83, 340.28) (1.64)

Fasting plasma glucose, mg/dl
<110

4534 (63.2)

4891 (68.2)

87.61 + 7.90

86.61 + 7.94

-1.00 (0.56,1.13) (-1.14)

110-125

1708 (23.8)

1270 (17.7)

108.40 + 6.91

108.06 + 6.93

-0.33 (7.13, 8.31) (-0.31)

>125

835 (11.6)

464 (6.5)

165.86 + 44.23

156.66 + 32.79

-6.12 (29.16, 34.29) (-5.54)

Systolic blood pressure, mmHg
<120

1563 (21.8)

2251 (31.4)

110.16 + 7.29

109.60 + 7.52

-0.56 (-2.71, -1.51) (-0.51)

120-139

3047 (42.5)

2959 (41.3)

128.73 + 5.85

127.97 + 5.75

-0.76 (4.44, 5.32) (-0.59)

140-160

1831 (25.5)

1121 (15.6)

147.94 + 6.43

147.01 + 6.23

-0.93 (12.88, 14.20) (-0.63)

>160

564 (7.9)

193 (2.7)

173.80 + 12.06

172.45 + 9.70

-1.35 (23.58, 26.93) (-0.78)

(Continued)
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Table 5
Descriptive Statistics Scores of Pre- and Postprogram Biometric Outcomes Categorized
by Disease Risk Factor (n=7,172)
Risk Factor

Preprogram

Postprogram

Preprogram

Postprogram

n (%)

n (%)

(Mean + SD)

(Mean + SD)

Mean change (95%
confidence interval) (%)

Diastolic blood pressure, mmHg
<80

3285 (45.8)

4101 (57.2)

70.49 + 6.41

69.79 + 6.76

-0.70 (-0.74, -0.08) (-0.99)

80-89

2366 (33.0)

1872 (26.1)

83.22 + 2.93

82.81 + 2.81

-0.41 (5.64, 6.33) (-0.49)

90-100

1171 (16.3)

501 (7.0)

93.69 + 3.56

93.12 + 3.36

-0.57 (10.20, 11.22) (-0.61)

>100

180 (2.5)

49 (0.7)

110.66 + 14.72

107.53 + 7.84

-3.13 (18.41, 24.42) (-2.83)

Body mass index, Kg/m²
<18.5

51 (0.7)

46 (0.6)

17.54 + 0.90

17.65 + 0.75

0.11 (-0.01, 0.33) (0.62)

18.5-24.9

1347 (18.8)

1555 (21.7)

22.68 + 1.63

22.66 + 1.64

-0.02 (0.43, 0.53) (-0.10)

25-29.9

2109 (29.4)

2049 (28.6)

27.48 + 1.41

27.47 + 1.43

-0.01 (0.84, 0.90) (-0.05)

≥30

3534 (49.3)

2860 (39.9)

36.82 + 6.19

36.42 + 5.96

-0.40 (1.26, 1.33) (-1.07)

Normality Testing
Prior to conducting the statistical analysis, statistical assumptions for normality of
the study variables on the population were tested to ensure that the data followed normal
distribution. Normality testing was only conducted on the study variables that were
continuously measured. These included the dependent variables of the biometrics (TC,
HDL, LDL, TG, FPG, SBP, DBP, and BMI) and age. The histograms for normality
testing on the population are presented in Appendix B.
Each study variable histogram distribution formed a bell-shaped curve pattern,
representing a normal distribution. Although the bell-shaped pattern formed in each of
the graphs was not a perfect representation, this is considered acceptable. Each biometric
variable and age exhibited a normal distribution; thus, the normality assumption for all
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the study variables was not violated.
Logistic Regression Results for Research Question One (RQ1)
The following research question guided this analysis:
RQ1: After controlling the effects of age, gender, marital status, BMI, and
parental death from diabetes before age 60, is there a statistically significant difference in
self-identified type 2 diabetes prevalence rates between Adventist and non-Adventist
CHIP participants preprogram between January 2006 and September 2012?
H01: The self-identified diabetes prevalence rate between Adventist and nonAdventist in pre-CHIP participants is not significantly different.
H11: The self-identified diabetes prevalence rate between Adventist and nonAdventist in pre-CHIP participants is significantly different.
The dependent variable tracked in answering RQ1 was self-identified diabetes.
The independent variables were religiosity and testing period. Five covariates were also
tracked: age, gender, marital status, BMI, and parental death from diabetes before age 60.
The quantitative test used to answer this question was logistic regression.
A logistic regression analysis was performed to investigate whether there was a
significant difference in the self-identified preprogram diabetic state between Adventists
and non-Adventists, while controlling for the covariate effects of age, gender, marital
status, BMI, and parental death from diabetes before age 60. The dependent variable of
self-identified diabetic state was a dichotomously measured variable with the binary
codes of 0 (no previous history with diabetes) and 1 (previous history with diabetes).
RQ1 aimed to compare Adventists and non-Adventists in self-identified prevalence rate
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of diabetes pre-CHIP program. A level of significance of 0.05 was used in the analysis.
The self-identified diabetes state between Adventists and non-Adventists would be
significantly related if the p-value of the effect of religion were less than or equal to the
level of significance value of 0.05.
The logistic regression model generated was a two-step approach. The first step
determined the effects of the covariates of age, gender, body mass index, marital status,
and parental death from type 2 diabetes before age 60, on the self-identified diabetes
state. The second step determined the effects of the independent variables of religiosity
and testing period on the diabetes state, while controlling for the effects of the covariates
of age, gender, marital status, BMI, and parental death from diabetes before age 60. The
covariates and the independent variables were treated as categorical variables in the
logistic regression model. Table 6 summarizes the logistic regression results with
confidence intervals and odds ratios
For step 1, the results showed that all of the covariates of age (Wald (1) = 191.55, p
< 0.001), gender (Wald (1) = 19.28, p < 0.001), BMI (Wald (1) = 494.16, p < 0.001),
marital status (Wald (1) = 16.34, p < 0.001), and parental death from diabetes before age
60 (Wald (1) = 165.30, p < 0.001) have significant effects on the dependent variable of
self-selected diabetic state. This suggested that there is a significant difference in the
preprogram diabetic state of the sample when there are differences in these covariates.
For step 2, the results showed that the independent variables of religiosity (Wald
(1) = 0.30, p = 0.58) and testing period (Wald (1) = 2.08, p = 0.15) did not have a
significant effect on the self-identified preprogram diabetic state, after controlling for the
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covariates. Therefore, the self-identified diabetes state between Adventists and nonAdventists pre-CHIP was not significantly different. The results of the logistic regression
failed to reject the null hypothesis for RQ1. The odds ratio of religiosity was 0.96 and the
odds ratio of testing period was 0.91. The effects of religiosity and testing period were
insignificant. The odds or probability of having preprogram diabetic state cannot be
dependent based on religiosity and testing period.
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Table 6
Logistic Regression Results of Effects of Diabetes State (n = 7,172)
95% C.I.for
EXP(B)

Variable
Age

B
0.04

SE
0.00

Wald
191.55

df
1

Sig.
0.00*

Exp
(B) /Odd
Ratio
Lower
1.04
1.03

Gender (1)

0.29

0.07

19.28

1

0.00*

1.34

0.66

0.85

Body mass index

0.09

0.00

494.16

1

0.00*

1.10

1.09

1.11

Marital status (1) 0.29
0.07
16.34
1
0.00*
1.33
0.66
Parental death
from type 2
1.45
0.11
165.30
1
0.00*
4.27
0.19
diabetes before
age 60 (1)
Constant
-7.07
0.24
838.37
1
0.00*
0.00
Step 2 Religiosity selfselected
affiliation as a
-0.04
0.08
0.30
1
0.58
0.96
0.90
Seventh-day
Adventist (1)
Testing period
-0.09
0.06
2.08
1
0.15
0.91
0.97
(1)
Constant
-7.03
0.25
818.75
1
0.00*
0.00
Notes. Variable(s) entered on Step 1: Age, Gender, Body Mass Index (BMI), Marital Status,
Parental death from type 2 diabetes before age 60. Independent Variable(s) entered on Step 2:
Religiosity self-identified affiliation as a Seventh-day Adventist, Testing period. Dependent
Variable: Diabetes State. *Significant at level of significance of ≤ 0.05

0.87

Step
Step 1

Upper
1.05

0.29

1.21

1.24

Repeated Measures MANOVA Results for Research Question Two (RQ2)
The following research question guided this analysis:
RQ2: After controlling for the effects of age, gender, marital status, and parental
death from diabetes before age 60, is there a statistically significant difference in the
change in biometric outcomes (TC, HDL, LDL, TG, FPG, SBP, DBP, and BMI) between
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Adventists and non-Adventists with self-identified diabetes pre- and post-CHIP between
January 2006 and September 2012?
H02: There is no statistically significant difference in biometric outcomes
between Adventists and non-Adventists with self-identified type 2 diabetes pre- and postCHIP.
H12: There is a statistically significant difference in biometric outcomes between
Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-CHIP.
The dependent variables tracked in answering RQ2 were TC, HDL, LDL, TG,
FPG, SBP, DBP, and BMI. The independent variables were religiosity and testing period.
The covariates were age, gender, marital status, and parental death from diabetes before
age 60. The quantitative test used to answer RQ2 was MANOVA.
Table 7 summarized the descriptive statistics of all the biometric outcomes
segregated between the Adventists with diabetes and non-Adventists with diabetes.
The highest percentage of Adventists and non-Adventist entered and exited CHIP
with a normal HDL, LDL, TG, FPG, and DBP. Adventists achieved a greater mean
change reduction in TC (-5.37 vs. -4.28), SBP (-2.59 vs. -1.42), DBP (-1.25 vs. -0.79),
and BMI (-0.42 vs. -0.26) than non-Adventists postclass. Non-Adventists achieved the
greatest mean change reduction postclass in the highest risk category of HDL (-1.70 vs. 0.48), LDL (-1.91 vs 7.87), TG (-68.34 vs. 11.0), and FPG (-12.74 vs. 6.12) over
Adventists. Adventists achieved the greatest mean change reduction postclass in the
highest risk category of TC (0.15 vs 3.27), SBP (-1.86 vs. -1.42), DBP (-1.25 vs. 1.95),
and BMI (-0.42 vs. -0.26). However, in every highest risk category both groups reduced
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the percentage of participants from pre- to postclass, and both groups increased the
percentage of participants in the normal category in LDL, TG, TC, FPG, SBP, DBP, and
BMI.
Table 8 presents the results of the repeated measures MANOVA. This determined
the main effect of whether the repeated measures statistics of the dependent variables of
the biometric outcomes in the pretest and posttest were significantly different due to
religious affiliation. It also determined whether the repeated measures and the betweensubject factor of religiosity have a two-way influence to each of the eight dependent
variables. A repeated measures MANOVA was conducted to determine whether the
dependent variables of the biometric outcomes were significantly different across the
independent variables, while controlling for the effects of the covariates. The repeated
measures MANOVA was performed to determine whether religiosity with diabetes and
testing period significantly accounted for variations in the biometric outcome
measurements. A level of significance of 0.05 was used in the MANOVA. Significant
differences in biometric outcomes were observed if the p-value of the F statistics of the
MANOVA was less than or equal to the level of significance set at 0.05. The withinsubject factor was the repeated measures scores or the testing periods (pretest and
posttest), and the between-subject factor was religiosity (Adventist or non-Adventist).
The interaction effects of the within-subject factor of the testing periods and the
between-subject factor of religiosity had significant effects on the biometric outcomes of
TC (F(1) = 5.65; p = 0.02) and LDL (F(1) = 5.76; p = 0.02). The interaction effects of the
within-subject factor of the testing periods and the between-subject factor of religiosity
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did not have any significant effects on the biometric outcomes of HDL (F(1) = 0.00; p =
0.99), TG (F(1) = 0.19, p = 0.67), FPG (F(1) = 2.71, p = 0.10), SBP (F(1) = 2.25; p =
0.13), DBP (F(1) = 1.20; p = 0.27), and BMI (F(1) = 1.65; p = 0.20). Only the biometric
outcomes of TC and LDL between the Adventists with diabetes and non-Adventists with
diabetes after they underwent the CHIP intervention were significantly different from the
pretest to the posttest, and was due to religious affiliation. The hypothesis, “There is a
significant difference in biometric outcomes between Adventists and non-Adventists with
self-identified type 2 diabetes pre- and post-CHIP,” was supported by the results of the
analysis, and therefore the null hypothesis for RQ2 was rejected. Although both groups
improved in all the other biometrics pre- to post-CHIP, these improvements were not due
to religious affiliation.
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Table 7
Descriptive Statistics Scores of Pre- and Postprogram Biometric Outcomes Between Adventists (n=210) and Non-Adventists With
Diabetes Categorized by Risk Factor Classification (n=836)
Adventists with diabetes
Baseline

30 d,

Risk
n (%)
n (%)
Factor
High-density lipoproteins, mg/dl
<40
52 (24.9)
77 (36.8)

Baseline
(Mean + SD)

30 d,
(Mean + SD)

Non-Adventists with diabetes
Mean change (95%
confidence interval)
(%)

Baseline

30 d,

Baseline

30 d,

n (%)

n (%)

(Mean + SD)

(Mean + SD)

33.44 + 5.06

32.65 + 5.13

-0.78 (1.09, 3.51) (2.34)

237 (28.3)

323 (38.6)

32.67 + 4.85

32.60 + 5.05

40-60

100 (47.8)

99 (47.7)

49.51 +5.64

48.70 + 6.28

-0.81 (2.60, 4.84) (1.64)

412 (49.3)

391 (46.8)

49.15 + 5.78

48.22 + 5.80

>60

57 (27.3)

33 (15.8)

73.31 + 17.15

72.83 + 14.09

-0.48 (5.11, 11.36) (0.65)

187 (22.4)

122 (14.6)

73.40 + 11.81

71.70 + 11.02

Mean change
(95% confidence
interval) (%)
-0.07 (-0.14, 0.06) (0.21)
-0.93 (2.99, 4.21)
(1.89)
-1.70 (7.21, 9.93)
(2.32)

Low-density lipoproteins, mg/dl
<100

77 (36.8)

131 (62.7)

79.91 + 15.47

78.34 + 15.08

-1.58 (5.03, 11.65) (1.97)

336 (40.2)

463 (55.4)

78.92 + 16.79

74.23 + 16.74

100-129

57(27.3)

47 (22.5)

113.74 + 9.37

114.89 + 8.07

1.15 (15.13, 20.93) (-1.01)

265 (31.7)

248 (29.7)

114.25 + 8.63

112.04 + 8.20

130-159

45 (21.5)

20 (9.6)

142.18 + 8.96

143.50 + 9.46

1.32 (17.82, 29.95) (-0.93)

164 (19.6)

99 (11.8)

142.22 + 8.30

142.70 + 9.15

160-190

22 (10.5)

8 (3.8)

171.44 + 8.60

169.50 + 8.68

-1.94 (15.11, 40.83) (1.13)

55 (6.6)

21 (2.5)

171.69 + 8.23

171.09 + 7.91

8 (3.8)

3 (1.4)

220.46 + 29.85

228.33 + 18.82

7.87 (15.32, 67.61) (-3.57)

16 (1.9)

5 (0.6)

204.11 + 11.53

202.20 +
12.72

>190

-4.69 (-0.22, 0.11) (5.94)
-2.21 (0.32, 0.48)
(1.93)
0.48 (0.78, 1.01) (0.34)
-0.60 (1.02, 1.52)
(0.35)
-1.91 (27.08,
51.45) (0.94)

Triglycerides, mg/dl
<150

127 (60.8)

147 (70.3)

89.84 + 32.14

94.87 + 30.64

5.03 (-12.68, -1.83) (-5.59)

531 (63.5)

592 (70.8)

93.62 + 29.73

95.64 + 29.84

150-199

35 (16.7)

34 (16.3)

168.81 + 11.39

172.01 + 14.27

3.20 (3.67, 32.50) (-1.90)

159 (19.0)

127 (15.2)

171.34 + 14.05

200-500

45 (21.5)

27 (12.9)

259.82 + 57.01

277.30 + 56.68

17.47 (22.67, 70.68) (-6.73)

140 (16.7)

114 (13.6)

274.29 + 68.97

2 (1)

1 (0.5)

639.00 + 59.40

650.00 (.)

11.00 (-2452.77, 2756.77)
(-1.72)

6 (0.7)

3 (0.4)

669.67 + 60.87

169.70 +
14.03
262.93 +
65.03
601.33 +
47.26

>500

2.02 (-9.68, -3.99)
(-2.16)
-1.64 (11.04,
24.73) (0.96)
-11.36 (35.54,
64.56) (4.14)
-68.34 (118.79,
502.21)
(10.21)

(continued)
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Table 7
Descriptive Statistics Scores of Pre- and Postprogram Biometric Outcomes Between Adventists (n=210) and Non-Adventists With
Diabetes Categorized by Risk Factor Classification (n=836)
Adventists with diabetes
Baseline
Risk
n (%)
Factor
Total cholesterol, mg/dl

30 d,
n (%)

Baseline

30 d,

(Mean + SD)

(Mean + SD)

Non-Adventists with diabetes
Mean change (95%
confidence interval)
(%)

Baseline

30 d,

Baseline

30 d,

n (%)

n (%)

(Mean + SD)

(Mean + SD)

<160

44 (21.1)

90 (43.1)

137.14 + 17.97

135.94 + 17.78

-1.20 (2.31, 13.35) (0.87)

201 (24)

367 (43.9)

160-199

65 (31.1)

77 (36.8)

179.10 + 11.12

178.08 + 11.82

-1.02 (15.64, 25.52) (0.57)

325 (38.9)

297 (35.5)

200-239

67 (32.1)

28 (13.4)

218.00 + 11.31

215.69 + 11.21

-2.31 (23.95, 34.85) (1.06)

224 (26.8)

143 (17.1)

240-280

23 (11)

10 (4.8)

257.47 + 9.29

252.10 + 10.27

-5.37 (26.81, 62.52) (2.09)

69 (8.3)

26 (3.1)

>280

10 (4.8)

4 (1.9)

307.60 + 30.29

307.75 + 28.63

0.15 (25.19, 80.61) (-0.05)

17 (2.0)

3 (0.4)

138.49 +
16.90
180.49 +
11.53
217.13 +
11.11
254.55 +
10.92
297.40 +
14.16

134.21 + 17.82
177.30 + 11.07
215.41 + 10.84
253.70 + 10.47
300.67 + 10.41

Mean change
(95% confidence
interval) (%)

-4.28 (0.89, 7.58)
(3.09)
-3.19 (15.11,
20.01) (1.77)
-1.72 (24.08,
30.67) (0.79)
-0.85 (30.09,
41.92) (0.33)
3.27 (28.81,
80.88) (-1.10)

Fasting plasma glucose, mg/dl
<110

166 (79.4)

178 (85.2)

91.52 + 8.30

89.05 + 9.08

-2.46 (0.63, 3.50) (2.69)

663 (79.3)

731 (87.4)

91.65 + 9.19

90.20 + 9.13

110-125

166 (8.1)

17 (8.1)

115.53 + 4.17

115.82 + 4.11

0.29 (3.79, 15.83) (-0.25)

78 (9.3)

40 (4.8)

116.59 + 4.49

115.79 + 4.68

>125

166 (12.4)

14 (6.7)

175.81 + 72.66

181.93 + 65.54

6.12 (11.94, 45.40) (-3.48)

95 (11.4)

65 (7.8)

170.99 +
47.60

158.25 + 33.24

-1.45 (22.95,
39.54) (1.58)
-0.80 (3.26,
12.02) (0.69)
-12.74 (22.95,
39.54) (7.45)

Systolic blood pressure, mmHg
<120

50 (23.9)

93 (44.5)

111.51 + 6.74

108.92 + 7.88

-2.59 (-0.40, -0.12) (2.32)

207 (24.8)

349 (41.7)

110.60 + 7.79

109.76 + 7.59

120-139

83 (39.7)

83 (39.7)

129.41 + 5.86

128.08 + 6.06

-1.33 (0.22, 0.50) (1.03)

350 (41.9)

339 (40.6)

129.04 + 5.95

128.43 + 5.90

140-160

55 (26.3)

26 (12.4)

146.71 + 5.63

147.73 + 6.21

1.02 (0.76, 1.20) (-0.70)

205 (24.5)

125 (15)

148.22 + 6.22

147.37 + 6.33

21 (10)

7 (3.3)

173.43 + 7.85

171.57 + 12.25

-1.86 (0.94, 1.82) (1.07)

74 (8.9)

23 (2.8)

174.68 +
12.41

173.26 + 7.88

>160

-0.84 (-0.39, 0.25) (0.76)
-0.61 (0.24, 0.38)
(0.47)
-0.85 (14.27,
18.47) (0.57)
-1.42 (1.05, 1.47)
(0.81)

(continued)
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Table 7
Descriptive Statistics Scores of Pre- and Postprogram Biometric Outcomes Between Adventists (n=210) and Non-Adventists With
Diabetes Categorized by Risk Factor Classification (n=836)
Adventists with diabetes
Baseline

30 d,

Risk
n (%)
n (%)
Factor
Diastolic blood pressure, mmHg

Baseline
(Mean + SD)

30 d,
(Mean + SD)

Non-Adventists with diabetes
Mean change (95%
confidence interval)
(%)

Baseline

30 d,

Baseline

30 d,

n (%)

n (%)

(Mean + SD)

(Mean + SD)

<80

117 (56)

145 (69.4)

69.07 + 7.04

70.15 + 6.44

1.08 (-3.77, -0.13) (-1.56)

430 (51.4)

572 (68.4)

70.11 + 6.70

70.17 + 6.46

80-89

57 (27.3)

52 (24.9)

83.37 + 2.87

83.38 + 2.97

0.01 (3.38, 7.32) (-0.01)

270 (32.3)

202 (24.2)

83.36 + 2.76

82.94 + 2.73

90-100

31 (14.8)

11 (5.3)

93.48 + 3.19

92.36 + 3.20

-1.12 (8.77, 15.44) (1.20)

114 (13.6)

60 (7.2)

93.87 + 3.34

93.08 + 3.24

4 (1.9)

1 (0.5)

104.25 + 2.87

103.00 (.)

-1.25 (-4.93, 41.43) (1.20)

22 (2.6)

2 (0.2)

107.55 + 7.04

109.50 + 2.12

5 (2.4)

25 (12)

17.20 + 1.73

17.15 + 1.43

-0.05 (0.22, 0.44) (0.27)

9 (1.1)

57 (6.8)

17.88 + 0.12

17.77 + 0.90

18.524.9
25-29.9

38 (18.2)

44 (21.1)

22.48 + 1.85

22.45 + 1.86

-0.04 (-0.04, 0.20) (0.17)

154 (18.4)

194 (23.2)

22.69 + 1.46

22.59 + 1.54

67 (32.1)

64 (30.6)

27.90 + 1.70

27.84 + 1.74

-0.06 (0.22, 0.44) (0.21)

284 (34.0)

275 (32.9)

27.83 + 1.72

27.87 + 1.77

≥30

99 (47.7)

76 (36.4)

37.31 + 6.87

36.88 + 7.32

-0.42 (0.25 , 0.62) (1.13)

389 (46.5)

310 (37.1)

37.82 + 5.94

37.56 + 5.56

>100

Mean change
(95% confidence
interval) (%)

0.06 (-0.21, 0.13) (-0.09)
-0.42 (0.46, 0.61)
(0.50)
-0.79 (0.92, 1.22)
(0.84)
1.95 (1.52, 2.29)
(-1.81)

Body mass index, Kg/m²
<18.5

-0.11 (-0,06,
0.04) (0.62)
-0.10 (-0.05,
0.05) (0.44)
0.04 (0.22, 0.35)
(-0.14)
-0.26 (0.27, 0.43)
(0.69)
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Table 8
Results of Tests of Within-Subjects and Between-Subjects Effects (n = 560)
Source
Testing Period

Testing Period * Religiosity
self-identified affiliation as
Seventh-day Adventist

Error (Testing Period)

Linear

Type III Sum
of Squares
275.82

HDL

Linear

54.10

1

54.10

2.14

0.14

LDL

Linear

463.85

1

463.85

1.71

0.19

TG

Linear

1072.83

1

1072.83

0.66

0.42

FPG

Measure
TC

Testing
Period

df
1

MS
275.82

F
0.83

Sig.
0.36

Linear

27.45

1

27.45

0.18

0.68

SBP

Linear

73.01

1

73.01

0.59

0.44

DBP

Linear

0.20

1

0.20

0.00

0.95

BMI

Linear

2.14

1

2.14

2.79

0.10

TC
HDL

Linear
Linear

1880.04
0.00

1
1

1880.04
0.00

5.65
0.00

0.02*
0.99

LDL

Linear

1558.66

1

1558.66

5.76

0.02*

TG

Linear

300.80

1

300.80

0.19

0.67

FPG

Linear

421.89

1

421.89

2.71

0.10

SBP

Linear

280.07

1

280.07

2.25

0.13

DBP

Linear

59.37

1

59.37

1.20

0.27

BMI

Linear

1.27

1

1.27

1.65

0.20

TC
HDL

Linear
Linear

186128.99
14115.78

559
559

332.97
25.25

LDL

Linear

151283.83

559

270.63

TG

Linear

905897.16

559

1620.57

FPG

Linear

86955.29

559

155.56

SBP

Linear

69443.99

559

124.23

DBP

Linear

27634.27

559

49.44

BMI

Linear

428.58

559

0.77
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Summary
This study aimed to compare religious affiliation and how each affected biometric
outcomes pre- and post-CHIP intervention in those with type 2 diabetes, and to assess if
Adventists or non-Adventists entered CHIP with different prevalent rates of diabetes. The
specific data analyses conducted include descriptive statistics, logistic regression
analysis, repeated measures MANOVA, and frequency and percentages.
The results of the logistic regression analysis showed that religious affiliation and
testing period did not have a significant effect on the self-identified preprogram diabetes
rate once step two was completed. The results of the logistic regression failed to reject the
null hypothesis for RQ1. The results of the repeated measures MANOVA showed that the
interaction effects of the within-subject factor of the testing periods and the betweensubject factor of religiosity had significant effects on the biometric outcomes of TC and
LDL. The null hypothesis for RQ2 was rejected; there was a significant difference in
biometric outcomes for TC and LDL between Adventists and non-Adventists with selfidentified type 2 diabetes pre- and post-CHIP, which were due to Adventist affiliation.
Pre- and post-CHIP Adventists had a higher TC and LDL than non-Adventists. When
compared to non-Adventists, having an Adventist affiliation revealed little difference preand post-CHIP in both the percentage of members who fell within the highest risk factor
range and those who fell within the normal range, and in some parameters scored worse.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The current standard U.S. dietary recommendations to prevent and reverse
diabetes do not address the root cause of diabetes; instead, diabetes is commonly
managed in the United States through medications and moderation of all foods,
regardless of their health value (ADA, 2016). A whole-food, plant-based, vegan diet
addresses the root cause of diabetes and can reverse and prevent this disease (Yokoyama
et al., 2014). A diet higher in animal protein increases the risk of diabetes while a diet
higher in vegetable protein reduces the risk (Malik, Li, Tobias, Pan & Hu, 2016;
Viguiliouk et al., 2015), with no threshold when further reduction of animal products
does not help (Campbell, Parpia, & Chen, 1998). This study addressed a gap in the
literature by assessing if having a particular religious affiliation had an influence on
biometric outcomes pre- and post-CHIP, a plant-based, vegan intervention program. The
purposes of this study were to determine the relationship between religiosity and
preprogram diabetes state, and to determine if there was a statistically significant
difference in the biometric changes between Adventists and non-Adventists with diabetes
pre- and post-CHIP in those with type 2 diabetes.
The logistic regression analysis in RQ1 failed to reject the null hypothesis. The IV
of religiosity and testing period did not have a significant effect on the self-identified
diabetes state between Adventists and non-Adventists, after controlling for the covariates.
The reported diabetes rates—78.8% of non-Adventists and 21.2% of Adventists—was
not significant because of the influence of the covariates, and the null hypothesis was not
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rejected. In RQ2, the repeated MANOVA analysis showed that biometric outcomes
between Adventists with diabetes and non-Adventists with diabetes were significantly
different due to religious affiliation in LDL and TC pre- and post-CHIP and therefore
rejected the null hypothesis. Both groups improved in the percentage of participants who
moved into the normal category for all biometrics. Both groups reduced the percentage of
participants who were in the highest risk category.
Interpretation of the Findings
Previous CHIP research has presented pre- and postbiometrics in general and in
gender differences (Kent et al., 2014; Morton et al., 2014a) but not in religious
differences. During the latter part of finishing this dissertation, Kent et al. (2015),
published new research that assessed biometric changes among religious affiliation
(Adventist and non-Adventist) pre- and post-CHIP. They reported that Adventists and
non-Adventists achieved similar biometric improvements post-CHIP though nonAdventists improved in more areas, and those who were in the greatest risk categories
improved the most, similar to previous CHIP findings (Kent et al., 2015). Though my
current research additionally targeted those with type 2 diabetes in addition to Adventist
affiliation, Kent at al. (2015), found similar outcomes; this shows that regardless of
participant’s Adventist or diabetes status, they can see improvements at the post-CHIP
intervention stage.
This study also showed that the self-identified diabetes state between Adventist
and non-Adventist in pre-CHIP participants was not found to be significantly different,
which was similar to the more recent publication on religiosity by Kent (2015). This was
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not surprising considering CHIP targets those with diabetes and other chronic diseases
and Adventists may be drawn to an Adventist health program. This group of Adventists
would not be representative of the entire denomination.
The present study showed that having a particular religious belief, either
Adventist or non-Adventist with diabetes, did elicit significant improvement differences
in LDL and TC pre- and post-CHIP and was due to religious affiliation. The other
biometrics improved also, but was due to factors other than religion, and may be due to
lifestyle factors not currently captured in the CHIP questionnaires, such as gender,
income, readiness to learn, and changes in medication, diet, and exercise. Adventists with
diabetes had a higher mean in the normal category preprogram for FPG and DBP.
Non-Adventists had a higher mean in the normal disease risk category
preprogram for HDL, LDL, TG, TC, SBP, and BMI. Postclass Adventists had a higher
mean in the normal category for HDL, LDL, SBP, and DBP. Non-Adventists had a
higher mean in the normal category for TG, TC, FPG, and BMI. Adventists had a higher
percentage of participants in the highest category preclass in HDL, LDL, TG, TC, FPG,
SBP, and BMI. Non-Adventists had a higher percentage of participants in the highest
preclass in DBP. Postclass Adventists had a higher percentage of participants in the
highest category in HDL, LDL, TG, TC, SBP, and DBP, where non-Adventists were
higher in BMI and FPG. Adventists made a greater mean change reduction in the highest
disease risk category in SBP, DBP, and BMI, and non-Adventists in HDL, LDL, TG, and
FPG. In the highest category, Adventists increased their postclass mean change LDL by
7.87, TG by 11.00, TC by 0.15, and FPG by 6.12. In the highest category, non-Adventists
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increased their postclass mean change TC by 3.27 and DBP by 1.95. Both groups
increased the percentage of participants who entered into a lower HDL category.
The literature review presented evidence showing the effectiveness of a
comprehensive plant-based, lifestyle program in the reduction of chronic disease such as
diabetes and cardiovascular disease, and has the potential to impact large numbers of
people while reducing health costs significantly (Shurney et al., 2012). Despite the lack
of a control group and selection bias, this study, with its large sample size, indicated that
the volunteer-delivered CHIP modification intervention program is an effective 30-day,
community-based, video-presented, plant-based, lifestyle program (Morton et al., 2014a).
The literature review pointed out that trained volunteers have improved health
indicators for chronic disease such heart failure (Siabani et al., 2014), CVD risk factors
(Rankin et al., 2012), and at-home exercise programs (Castro, Pruitt, Buman, & King,
2011; Etkin, Prohaska, Harris, Latham, & Jette, 2006). The only apparent adverse
outcome in CHIP was the increase of participants who reduced their HDL, which has also
been seen throughout other CHIP research and other plant-based, vegan health programs.
Although its implications are disputed, a reduction is not considered a detriment when
switching to a plant-based diet (Barnard, 1991; Esselstyn et al., 1995; Kent et al., 2013b;
Kent et al., 2015; Morton et al., 2013; Ornish et al., 1998; Rankin et al., 2012), or when
accompanied by a normal LDL (Bartlett et al., 2016).
The social ecological model (Bronfenbrenner, 1979) depicts how the Adventist
health message has influenced the five social levels of society: individual, intrapersonal,
community, institutional, and societal, and how CHIP intersected with three: individual,
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intrapersonal, and community. The five social levels have a greater effect on an
individual’s health outcomes when combined and accumulated (Raingruber, 2014, p. 64).
Targeting one specific social level about health would not be as effective as
simultaneously concentrating on multiple health factors considering healthy and
unhealthy lifestyle principles come from each social level in reciprocal influences
(Raingruber, 2014, p. 64) and may be indicative of research outcomes in this study.
This research supports positive social change by showing that CHIP is a valuable
contributor and model program for improving chronic health indicators for all people,
regardless of Adventist affiliation. This study contributed original knowledge to the
existing CHIP literature by extending the population’s characteristics to add a specific
disease process, comparing a specific faith affiliation, and adding covariates. The
variables and population characteristics of the present study were not unlike previous
CHIP studies, thus it contributed additional empirical evidence to the field.
Limitations of the Study
Several limitations of this study were present. First, there was a lack of a control
group, which limits the generalization of the results of this study. However, Rockford
CHIP, the professional division of CHIP, has published research using randomized
clinical control trials, with results showing similar positive outcomes as the volunteer
division (Aldana et al., 2005a; Aldana et al., 2005b; Merrill, Taylor, & Aldana, 2008).
Second, diet, exercise, and medication diaries were not obtained from CHIP
participants, so it was unknown as to how much change there was to these variables, and
the effects those changes had on the biometric outcomes. However, participants informed
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facilitators that they had either reduced or removed their medications by doctor’s order
and made other lifestyle changes (Rankin et al., 2012). Had this data been factored into
the results, it would have only produced a diluted effect considering diet, exercise and
medications have direct effects on the biometrics used in this study. Factoring out these
variables would only strengthen the results. Other variables not captured but may have
contributed to the outcome of this study include race, social and church support, income,
and readiness to learn; thus, the influence of these variables in this study were also not
possible to measure.
Third, participants were self-identified in diabetes state, Adventist affiliation, and
class participation. Participants were asked on the Lifestyle Questionnaire, “Have you
ever been told by a doctor you have diabetes?” Therefore, they were self-identified, and
their diabetes state or type was not verified. It is possible that those with gestational
diabetes, type 1, or 1.5 (as opposed to type 2 diabetes that the present study focused on)
may have been included in the self-identification. Considering that 90-95% of people
with diabetes have type 2 (ADA, 2016), the number of other types of diabetes likely
would have been very negligible. There were also 86 children in the population group,
but none were listed as having diabetes.
It is also possible that participants may have not accurately checked their
Adventist status. Membership verification was not clarified, nor was the option to mark
Adventist or non-Adventist defined. Some participants who marked their Adventist
affiliation may have had loose associations with the church and others may have been
frequent visitor but not members, others may have simply missed the question.
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Participants were also self-selected to participate in the CHIP program, and may have
been more motivated, ready, and willing to make the necessary changes to a plant-based
diet (Bartholomew et al., 2006, p. 110-113).
Lastly, original CHIP data were input into the CHIP online databank by the local
facilitators and a cleaned up data set shared for this research; it is unknown if errors
occurred during data entry at any point. Considering other CHIP outcomes are all similar,
this again suggests that such errors, if they existed, had a negligible effect. Further
limitations and biases would have been minimal, since this research used secondary data,
and the trial planning and trial implementation had already occurred.
Recommendations
CHIP is an effective 30-day lifestyle modification program in reducing chronic
disease risk factors in both Adventists and non-Adventists with diabetes. However,
Adventist affiliation influenced participants significantly pre- and post-CHIP. Further
research recommendations include:
•

additional studies comparing Adventists and non-Adventists in other
disease processes

•

investigating further the reduction of HDL in those switching to a plantbased diet and incorporating those things into the program which are
known to have a positive effect on HDL such as omega-3, DHA, and ALA
supplementation

•

using a control group with the volunteer leg for broader generalizations

•

capturing diet, race, income, medication usage changes, and exercise
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•

validating diabetes state per ADA standards by a glycohemoglobin A1c or
two FPG tests (ADA, 2016)

•

comparing those who self-identify themselves as having diabetes on the
health questionnaire and the single FPG obtained preprogram

•

incorporating an additional teaching session which focuses on trust in God
as part of the Adventist health message and compare outcomes with a
control group

•

questioning how long the Adventists have been a baptized member to
compare outcome differences among themselves
Implications for Practice

Since the mid-1800s, the Adventist health message has been a source of
inspiration, optimism, strength, and guidance for those facing a variety of health
challenges without the use of medications. This message, as presented through CHIP,
advocates a nonmedical, lifestyle approach to improve disease outcomes for people
regardless of faith affiliation. The foundational causes, as well as treatment for managing
and reversing type 2 diabetes, are diet and lifestyle, but these factors are often given little
attention over Western medicine’s dietary approach and its costly, often ineffective,
pharmaceutical approaches, which are often prescribed despite their side effects (Graham
et al., 2010; Kannan et al., 2016; Lincoff, Wolski, Nicholls, & Nissen, 2007; Solomon &
Winkelmayer, 2007). CHIP is a desired program for those who want a natural approach
to diabetes prevention and reversal without the use of pharmaceuticals. The positive
social impact is that CHIP has demonstrated that regardless of having a specific faith
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(Kent et al., 2015), those with type 2 diabetes may also attend CHIP, apply the principles
to their own lives, and expect to see similar improvements.
Considering the strong educational component of CHIP, as well as its solid,
scientifically researched foundation, and the fact that the program does not demand
adherence to an Adventist ideology (and provides limited spiritual teaching in general
because it targets a more secular community), introducing this program in places that care
for those with chronic disease may be beneficial. Incorporating CHIP into hospitals, longterm care facilities, prisons, and other large and small institutions, workplaces, and the
home setting may be effective in reducing both morbidity and mortality due to chronic
disease, as well as realizing a substantial cost benefit (Leung et al., 2015). Considering
that religion plays a role in health and healing (McKenzie, Modeste, Marshak, & Wilson,
2015; Snowdon et al., 1982), and trusting in God is an Adventist health principle, it is
reasonable to investigate whether a more focused spiritual approach affect health
outcomes. Additional research using a control group with trusting in God as an additional
teaching module may prove beneficial.
Conclusion
This chapter contained the analysis interpretation of comparing Adventists and
non-Adventists with diabetes pre- and post-CHIP intervention, a volunteer-facilitated,
plant-based, community health program to improve chronic disease risk factor outcomes.
The diabetes rate was also discussed between the two groups. MANOVA, logistic
regression, frequencies, and percentages were used to analyze and describe the data.
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Over the past many decades, much research has been published and dedicated to
assessing a plant-based, vegan diet as an intervention to reverse and prevent type 2
diabetes. Counsel on this lifestyle has been given since the time of Hippocrates and
progressively throughout the Adventist movement for the past almost 160 years. A
whole-foods, vegan diet is a viable prescription for individuals with diabetes willing to
follow such a plan especially if they desire a pharmaceutical-free approach. The results of
this study add empirical data to the existing literature, which shows the need for a
paradigm shift in treating diabetes. A positive social change begins at any of the five
levels of society and can have a spreading and pervasive influence as seen with the
spread of the Adventist health message going worldwide and depicted through the SEM.
This study has shown that both Adventists and non-Adventists with diabetes
benefit from applying CHIP’s nutrient-dense, whole-food, plant-based dietary principles,
but more so for non-Adventists in LDL and TC. Overall, both groups improved in all
areas. A diet high in plant foods without the additional use of animal products, coupled
with other practical and timeless lifestyle principles, is an effective means to improve
biometric outcomes for those with type 2 diabetes. Programs such as CHIP are needed at
a time when chronic disease is at an all-time high, and will be necessary to expand this
and other similar programs if there is to be a reduction in chronic disease rates, not only
in North America but also worldwide.
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